<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>COVID-19 mRNA vaccines: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">COVID-19 mRNA vaccines: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">COVID-19 mRNA vaccines: Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="130318" href="/d/html/130318.html" rel="external">see "COVID-19 mRNA vaccines: Drug information"</a> and <a class="drug drug_patient" data-topicid="130324" href="/d/html/130324.html" rel="external">see "COVID-19 mRNA vaccines: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F55194836"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Comirnaty;</li>
<li>Moderna COVID-19 Vac 6m-11y;</li>
<li>Pfizer COVID-19 Vac-TriS 5-11y;</li>
<li>Pfizer COVID-19 Vac-TriS 6m-4y;</li>
<li>Spikevax</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F55194837"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Comirnaty;</li>
<li>Comirnaty (Gray Cap);</li>
<li>Comirnaty (Purple Cap);</li>
<li>Comirnaty Omicron XBB.1.5;</li>
<li>Comirnaty Original &amp; Omicron;</li>
<li>Spikevax;</li>
<li>Spikevax Bivalent;</li>
<li>Spikevax Orig &amp; Omicron BA.4/5;</li>
<li>Spikevax XBB.1.5</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F55189601"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Vaccine</span>;</li>
<li>
<span class="list-set-name">Vaccine, Inactivated (Viral)</span></li></ul></div>
<div class="block dop drugH1Div" id="F55187087"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="1816035d-6a14-4ee1-9e09-06e166640b6c">COVID-19 prevention</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>COVID-19 prevention:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> The only mRNA COVID-19 vaccines approved for use in the United States are based on the SARS-CoV-2 Omicron variant XBB.1.5 and labeled "2023-2024 Formula". Emergency use authorization is no longer available for previous formulations (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-FDA.13','lexi-content-ref-FDA.14']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-FDA.13','lexi-content-ref-FDA.14'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Infants ≥6 months and Children &lt;5 years: IM: Dosing based on vaccine product and mRNA COVID-19 vaccination history; tables for patients with and without moderate to severe immunocompromising conditions are separate; use caution. It is recommended that patients in this age group receive all doses from the same manufacturer (CDC 2023).</p>
<table border="1" frame="border" rules="all" style="margin-left:6em;">
<caption style="text-align:left;">Pediatric COVID-19 Vaccine (mRNA) 2023-2024 Formulation Dose Recommendations for Patients <b>6 Months to &lt;5 Years</b> of Age WITHOUT Moderate to Severe Immunocompromising Conditions or Treatment (CDC 2023)</caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead valign="top">
<tr>
<th align="left">
<p style="text-indent:0em;">Manufacturer</p></th>
<th align="left">
<p style="text-indent:0em;">
<b>COVID-19 mRNA vaccine history (prior to 2023-2024 formulation)</b></p></th>
<th align="left">
<p style="text-indent:0em;">Vial description</p></th>
<th align="left">
<p style="text-indent:0em;">Total amount of mRNA per dose</p></th>
<th align="left">
<p style="text-indent:0em;">
<b>Number of 2023-2024 formulation doses indicated (administer IM)</b></p></th>
<th align="left">
<p style="text-indent:0em;">Interval between doses</p></th></tr></thead>
<tfoot valign="top">
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>a</sup> Vaccination series should be from the same manufacturer if possible. A different age-appropriate COVID-19 vaccine may be administered in some circumstances (ie, same vaccine not available at the vaccination site at the time of the clinic visit, previous dose unknown, person would otherwise not receive a recommended vaccine dose, or person starts but is unable to complete a vaccination series with the same COVID-19 vaccine due to a contraindication).</p></td></tr>
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>b </sup>An 8-week interval between the first and second doses might be optimal for some people, as it might reduce the small risk of myocarditis and pericarditis associated with these vaccines.</p></td></tr>
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>c </sup>For children who transition from age 4 to 5 years during the Pfizer-BioNTech vaccination series, it is recommended to complete the series with the Pfizer-BioNTech product supplied with blue caps and blue label borders for 5 to &lt;12 years (10 mcg per 0.3 mL); alternatively, the series may be completed with the product supplied with yellow caps and yellow label borders.</p></td></tr></tfoot>
<tbody valign="top">
<tr>
<td align="left" rowspan="3">
<p style="text-indent:0em;">Moderna product<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Green label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">25 mcg per 0.25 mL</p></td>
<td align="left">
<p style="text-indent:0em;">2 doses</p></td>
<td align="left">
<p style="text-indent:0em;">Administer second dose 4 to 8 weeks following the first dose.<sup>b</sup></p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">1 dose of any previous Moderna formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Green label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">25 mcg per 0.25 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">Administer dose 4 to 8 weeks after last dose of previous formulation.<sup>b</sup></p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥2 doses of any previous Moderna formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Green label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">25 mcg per 0.25 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥8 weeks after last dose of previous formulation.</p></td></tr>
<tr>
<td align="left" rowspan="3">
<p style="text-indent:0em;">Pfizer-BioNTech products<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Yellow label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">3 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">3 doses<sup>c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer second dose 3 to 8 weeks after first, then administer third dose ≥8 weeks after second.<sup>b</sup></p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">1 dose of any previous Pfizer-BioNTech formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Yellow label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">3 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">2 doses<sup>c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer first dose 3 to 8 weeks after dose of previous formulation, then administer second dose ≥8 weeks after first 2023-2024 formulation dose.<sup>b</sup></p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥2 doses of any previous Pfizer-BioNTech formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Yellow label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">3 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">Administer dose ≥8 weeks after last dose of previous formulation.</p></td></tr></tbody></table>
<table border="1" frame="border" rules="all" style="margin-left:8em;">
<caption style="text-align:left;">Pediatric COVID-19 Vaccine (mRNA) <b>2023-2024 Formulation </b>Dose Recommendations for Patients <b>6 Months to &lt;5 Years</b> of Age WITH Moderate to Severe Immunocompromising Conditions or Treatment (CDC 2023)</caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead valign="top">
<tr>
<th align="left">
<p style="text-indent:0em;">Manufacturer</p></th>
<th align="left">
<p style="text-indent:0em;">
<b>COVID-19 mRNA vaccine history (prior to 2023-2024 formulation)</b></p></th>
<th align="left">
<p style="text-indent:0em;">Vial description</p></th>
<th align="left">
<p style="text-indent:0em;">Total amount of mRNA per dose</p></th>
<th align="left">
<p style="text-indent:0em;">Number of <b>2023-2024 formulation </b> doses indicated<sup>a</sup> (administer IM)</p></th>
<th align="left">
<p style="text-indent:0em;">Interval between doses</p></th></tr></thead>
<tfoot valign="top">
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>a</sup> Persons 6 months to &lt;5 years of age who are moderately or severely immunocompromised may receive an additional age- and product-appropriate dose of a 2023-2024 formulation mRNA vaccine ≥2 months following the last recommended 2023-2024 formulation mRNA COVID-19 dose. Further additional doses may be administered, informed by the clinical judgment of a health care provider and personal preference and circumstances.</p></td></tr>
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>b</sup> Vaccination series should be from the same manufacturer if possible. A different age-appropriate COVID-19 vaccine may be administered in some circumstances (ie, same vaccine not available at the vaccination site at the time of the clinic visit, previous dose unknown, person would otherwise not receive a recommended vaccine dose, or person starts but is unable to complete a vaccination series with the same COVID-19 vaccine due to a contraindication).</p></td></tr>
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>c</sup> For children who transition from age 4 to 5 years during the Pfizer-BioNTech vaccination series, it is recommended to complete the series with the Pfizer-BioNTech product supplied with blue caps and blue label borders for 5 to &lt;12 years (10 mcg per 0.3 mL); alternatively, the series may be completed with the product supplied with yellow caps and yellow label borders.</p></td></tr></tfoot>
<tbody valign="top">
<tr>
<td align="left" rowspan="4">
<p style="text-indent:0em;">Moderna products<sup>b</sup></p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Green label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">25 mcg per 0.25 mL</p></td>
<td align="left">
<p style="text-indent:0em;">3 doses<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer second dose 4 weeks following the first dose, and third dose ≥4 weeks following the second.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">1 dose of any previous Moderna formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Green label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">25 mcg per 0.25 mL</p></td>
<td align="left">
<p style="text-indent:0em;">2 doses<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer first dose 4 weeks following the dose of previous formulation, then administer second dose ≥4 weeks after the first 2023-2024 formulation dose.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">2 doses of any previous Moderna formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Green label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">25 mcg per 0.25 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer dose ≥4 weeks after the last dose of previous formulation.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥3 doses of any previous Moderna formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Green label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">25 mcg per 0.25 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥8 weeks after the last dose of previous formulation.</p></td></tr>
<tr>
<td align="left" rowspan="3">
<p style="text-indent:0em;">Pfizer-BioNTech products<sup>b</sup></p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Yellow label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">3 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">3 doses<sup>a,c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer second dose 3 weeks after first, then administer third dose ≥8 weeks after second.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">1 dose of any previous Pfizer-BioNTech formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Yellow label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">3 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">2 doses<sup>a,c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer first dose 3 weeks after dose of previous formulation, then administer second dose ≥8 weeks after first 2023-2024 formulation dose.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥2 doses of any previous Pfizer-BioNTech formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Yellow label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">3 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer dose ≥8 weeks after last dose of previous formulation.</p></td></tr></tbody></table>
<p style="text-indent:-2em;margin-left:4em;">Children 5 to &lt;12 years: IM: Dosing based on vaccine product and mRNA COVID-19 vaccination history; tables for patients with and without moderate to severe immunocompromising conditions are separate; use caution. For patients with moderate to severe immunocompromising conditions, the first 3 doses are recommended to be from the same manufacturer (CDC 2023).</p>
<table border="1" frame="border" rules="all" style="margin-left:6em;">
<caption style="text-align:left;">Pediatric COVID-19 Vaccine (mRNA) <b>2023-2024 Formulation </b>Dose Recommendations for Patients 5<b> to &lt;12 Years</b> of Age WITHOUT Moderate to Severe Immunocompromising Conditions or Treatment (CDC 2023)</caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead valign="top">
<tr>
<th align="left">
<p style="text-indent:0em;">Manufacturer</p></th>
<th align="left">
<p style="text-indent:0em;">
<b>COVID-19 mRNA vaccine history (prior to 2023-2024 formulation)</b></p></th>
<th align="left">
<p style="text-indent:0em;">Vial description</p></th>
<th align="left">
<p style="text-indent:0em;">Total amount of mRNA per dose</p></th>
<th align="left">
<p style="text-indent:0em;">Number of <b>2023-2024 formulation </b> doses indicated (administer IM)</p></th>
<th align="left">
<p style="text-indent:0em;">Interval between doses</p></th></tr></thead>
<tfoot valign="top">
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>a</sup> For children who transition from age 4 to 5 years during the Pfizer-BioNTech vaccination series, it is recommended to complete the series with the Pfizer-BioNTech product supplied with blue caps and blue label borders; alternatively, the series may be completed with the product supplied with yellow caps and yellow label borders (for patients 6 months to &lt;5 years; 3 mcg per 0.3 mL).</p></td></tr></tfoot>
<tbody valign="top">
<tr>
<td align="left" rowspan="2">
<p style="text-indent:0em;">Moderna products</p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Green label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">25 mcg per 0.25 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥1 dose of any previous vaccine formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Green label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">25 mcg per 0.25 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥8 weeks after last dose of previous formulation.</p></td></tr>
<tr>
<td align="left" rowspan="2">
<p style="text-indent:0em;">Pfizer-BioNTech products<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">10 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥1 dose of any previous mRNA vaccine formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">10 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥8 weeks after last dose of previous formulation.</p></td></tr></tbody></table>
<table border="1" frame="border" rules="all" style="margin-left:6em;">
<caption style="text-align:left;">Pediatric COVID-19 Vaccine (mRNA) <b>2023-2024 Formulation </b>Dose Recommendations for Patients 5<b> to &lt;12 Years</b> of Age WITH Moderate to Severe Immunocompromising Conditions or Treatment<sup>a</sup> (CDC 2023)</caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead valign="top">
<tr>
<th align="left">
<p style="text-indent:0em;">Manufacturer</p></th>
<th align="left">
<p style="text-indent:0em;">
<b>COVID-19 mRNA vaccine history (prior to 2023-2024 formulation)</b></p></th>
<th align="left">
<p style="text-indent:0em;">Vial description</p></th>
<th align="left">
<p style="text-indent:0em;">Total amount of mRNA per dose</p></th>
<th align="left">
<p style="text-indent:0em;">Number of <b>2023-2024 formulation </b> doses indicated<sup>a</sup> (administer IM)</p></th>
<th align="left">
<p style="text-indent:0em;">Interval between doses</p></th></tr></thead>
<tfoot valign="top">
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>a</sup> Persons 5 to &lt;12 years of age who are moderately or severely immunocompromised may receive an additional age-appropriate dose of a 2023-2024 formulation mRNA vaccine ≥2 months following the last recommended 2023-2024 mRNA COVID-19 dose. Further additional 2023-2024 formulation doses may be administered, informed by the clinical judgment of a health care provider and personal preference and circumstances.</p></td></tr>
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>b</sup> Individuals transitioning from age 11 to 12 years during the initial vaccination series are recommended to receive the dose for ≥12 years of age for all doses after turning 12 years of age; however, they may also complete series with the dose for 5 to &lt;12 years of age.</p></td></tr>
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>c</sup> Vaccination series should be from the same manufacturer if possible. A different age-appropriate COVID-19 vaccine may be administered in some circumstances (ie, same vaccine not available at the vaccination site at the time of the clinic visit, previous dose unknown, person would otherwise not receive a recommended vaccine dose, or person starts but is unable to complete a vaccination series with the same COVID-19 vaccine due to a contraindication).</p></td></tr>
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>d</sup> For children who transition from age 4 to 5 years during the Pfizer-BioNTech vaccination series, it is recommended to complete the series with the Pfizer-BioNTech product supplied with blue caps and blue label borders; alternatively, the series may be completed with the product supplied with yellow caps and yellow label borders (for patients 6 months to &lt;5 years; 3 mcg per 0.3 mL).</p></td></tr></tfoot>
<tbody valign="top">
<tr>
<td align="left" rowspan="4">
<p style="text-indent:0em;">Moderna products<sup>b</sup></p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Green label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">25 mcg per 0.25 mL</p></td>
<td align="left">
<p style="text-indent:0em;">3 doses<sup>a,c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer second dose 4 weeks following the first dose, and third dose ≥4 weeks following the second.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">1 dose of any previous Moderna formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Green label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">25 mcg per 0.25 mL</p></td>
<td align="left">
<p style="text-indent:0em;">2 doses<sup>a,c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer first dose 4 weeks following the dose of previous formulation, and administer second dose ≥4 weeks after the first 2023-2024 formulation dose.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">2 doses of any previous Moderna formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Green label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">25 mcg per 0.25 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a,c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer dose ≥4 weeks after the last dose of previous formulation.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥3 doses of any previous mRNA COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Green label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">25 mcg per 0.25 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥8 weeks after the last dose of previous formulation.</p></td></tr>
<tr>
<td align="left" rowspan="4">
<p style="text-indent:0em;">Pfizer-BioNTech products<sup>b,d</sup></p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">10 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">3 doses<sup>a,c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer second dose 3 weeks following the first dose, and administer third dose ≥4 weeks after the second.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">1 dose of any previous Pfizer-BioNTech formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">10 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">2 doses<sup>a,c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer the first dose 3 weeks after the dose of previous formulation, and administer the second dose ≥4 weeks after the first 2023-2024 formulation dose.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">2 doses of any previous Pfizer-BioNTech formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">10 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a,c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥4 weeks after the last dose of previous formulation.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥3 doses of any previous mRNA COVID-19 vaccine formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">10 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥8 weeks after the last dose of previous formulation.</p></td></tr></tbody></table>
<p style="text-indent:-2em;margin-left:4em;">Children ≥12 years and Adolescents: IM: Dosing based on vaccine product and mRNA COVID-19 vaccination history; tables for patients with and without moderate to severe immunocompromising conditions are separate; use caution. For patients with moderate to severe immunocompromising conditions, the first 3 doses are recommended to be from the same manufacturer (CDC 2023).</p>
<table border="1" frame="border" rules="all" style="margin-left:6em;">
<caption style="text-align:left;">
<b>Pediatric COVID-19 Vaccine (mRNA) 2023-2024 Formulation Dose Recommendations for Patients ≥12 Years of Age WITHOUT Moderate to Severe Immunocompromising Conditions or Treatment (CDC 2023)</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead valign="top">
<tr>
<th align="left">
<p style="text-indent:0em;">Manufacturer</p></th>
<th align="left">
<p style="text-indent:0em;">
<b>COVID-19 mRNA vaccine history (prior to 2023-2024 formulation)</b></p></th>
<th align="left">
<p style="text-indent:0em;">Vial description</p></th>
<th align="left">
<p style="text-indent:0em;">Total amount of mRNA per dose</p></th>
<th align="left">
<p style="text-indent:0em;">Number of <b>2023-2024 formulation </b> doses indicated (administer IM)</p></th>
<th align="left">
<p style="text-indent:0em;">Interval between doses</p></th></tr></thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="2">
<p style="text-indent:0em;">Moderna products</p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">50 mcg per 0.5 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥1 dose of any previous COVID-19 vaccine formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">50 mcg per 0.5 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥8 weeks after last dose of previous formulation.</p></td></tr>
<tr>
<td align="left" rowspan="2">
<p style="text-indent:0em;">Pfizer-BioNTech products</p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Gray label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">30 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥1 dose of any previous mRNA vaccine formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Gray label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">30 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥8 weeks after last dose of previous formulation.</p></td></tr></tbody></table>
<table border="1" frame="border" rules="all" style="margin-left:6em;">
<caption style="text-align:left;">
<b>Pediatric COVID-19 Vaccine (mRNA) 2023-2024 Formulation Dose Recommendations for Patients ≥12 Years of Age WITH Moderate to Severe Immunocompromising Conditions or Treatment (CDC 2023)</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead valign="top">
<tr>
<th align="left">
<p style="text-indent:0em;">Manufacturer</p></th>
<th align="left">
<p style="text-indent:0em;">
<b>COVID-19 mRNA vaccine history (prior to 2023-2024 formulation)</b></p></th>
<th align="left">
<p style="text-indent:0em;">Vial description</p></th>
<th align="left">
<p style="text-indent:0em;">Total amount of mRNA per dose</p></th>
<th align="left">
<p style="text-indent:0em;">Number of <b>2023-2024 formulation </b> doses indicated<sup>a</sup> (administer IM)</p></th>
<th align="left">
<p style="text-indent:0em;">Interval between doses</p></th></tr></thead>
<tfoot valign="top">
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>a</sup> Persons ≥12 years of age who are moderately or severely immunocompromised may receive an additional age-appropriate dose of a 2023-2024 formulation mRNA vaccine ≥2 months following the last recommended 2023-2024 mRNA COVID-19 dose. Further additional 2023-2024 formulation doses may be administered, informed by the clinical judgment of a health care provider and personal preference and circumstances.</p></td></tr>
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>b</sup> Individuals transitioning from age 11 to 12 years during the initial vaccination series are recommended to receive the dose for ≥12 years of age for all doses after turning 12 years of age; however, they may also complete series with the dose for 5 to &lt;12 years of age.</p></td></tr>
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup>c</sup> Initial 3-dose vaccination series should be from same manufacturer if possible. A different age-appropriate COVID-19 vaccine may be administered in some circumstances (ie, same vaccine not available at the vaccination site at the time of the clinic visit, previous dose unknown, person would otherwise not receive a recommended vaccine dose, or person starts but is unable to complete a vaccination series with the same COVID-19 vaccine due to a contraindication).</p></td></tr></tfoot>
<tbody valign="top">
<tr>
<td align="left" rowspan="4">
<p style="text-indent:0em;">Moderna products<sup>b</sup></p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">50 mcg per 0.5 mL</p></td>
<td align="left">
<p style="text-indent:0em;">3 doses<sup>a,c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer second dose 4 weeks following the first dose, and third dose ≥4 weeks following the second.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">1 dose of any previous Moderna formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">50 mcg per 0.5 mL</p></td>
<td align="left">
<p style="text-indent:0em;">2 doses<sup>a,c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer first dose 4 weeks following the dose of previous formulation, and administer second dose ≥4 weeks after the first 2023-2024 formulation dose.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">2 doses of any previous Moderna formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">50 mcg per 0.5 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer dose ≥4 weeks after the last dose of previous formulation.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥3 doses of any previous mRNA COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">50 mcg per 0.5 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥8 weeks after the last dose of previous formulation.</p></td></tr>
<tr>
<td align="left" rowspan="4">
<p style="text-indent:0em;">Pfizer-BioNTech products<sup>b</sup></p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Gray label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">30 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">3 doses<sup>a,c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer second dose 3 weeks following the first dose, and administer third dose ≥4 weeks after the second.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">1 dose of any previous Pfizer-BioNTech formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Gray label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">30 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">2 doses<sup>a,c</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer the first dose 3 weeks after the dose of previous formulation, and administer the second dose ≥4 weeks after the first 2023-2024 formulation dose.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">2 doses of any previous Pfizer-BioNTech formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Gray label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">30 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥4 weeks after the last dose of previous formulation.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥3 doses of any previous mRNA COVID-19 vaccine formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Gray label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">30 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥8 weeks after the last dose of previous formulation.</p></td></tr></tbody></table>
<p style="text-indent:-2em;margin-left:4em;">
<i>
<b>Canadian and international recommendations</b>:</i> Preparations of COVID-19 mRNA vaccines containing different components (eg, SARS-CoV-2 Original strain, Omicron BA.1, BA.4/BA.5, and XBB.1.5 variants) may be available. Recommendations related to use of these preparations and approved ages may vary per country; consult local product labeling. The Canadian National Advisory Committee on Immunization (NACI) provides different recommendations as compared to the CDC, including longer intervals; see NACI recommendations for details. The NACI recommends that beginning in fall 2023, persons who were previously vaccinated against COVID-19 receive a dose of an age-appropriate XBB.1.5 variant-containing COVID-19 vaccine if it has been ≥6 months from the previous COVID-19 vaccine dose or known SARS-CoV-2 infection (whichever is later) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-NACI.1','lexi-content-ref-NACI.3','lexi-content-ref-NACI.4']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-NACI.1','lexi-content-ref-NACI.3','lexi-content-ref-NACI.4'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Revaccination:</b> For patients who received ≥1 doses of COVID-19 vaccine prior to or while receiving a hematopoietic cell transplant (HCT) or chimeric antigen receptor (CAR)–T-cell therapy, revaccination is recommended; revaccinate when ≥3 months post HCT or CAR-T-cell therapy. In patients who received ≥1 doses of COVID-19 vaccine during treatment with B-cell–depleting therapies (eg, rituximab, ocrelizumab) that were administered over a limited period (eg, as part of a treatment regimen for certain malignancies), revaccination may be considered ~6 months after completion of B-cell–depleting therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.5']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.5'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Dosing recommendations for deviations in administration, preparation, or storage:</b></p>
<table border="1" frame="border" rules="all">
<caption style="text-align:left;">
<b>Recommendations for Deviations in COVID-19 Vaccine Usage (CDC 2023)</b></caption>
<colgroup><col align="center"/>
<col align="center"/>
</colgroup><thead>
<tr>
<th align="center">
<p style="text-indent:0em;text-align:left;">Deviation</p></th>
<th align="center">
<p style="text-indent:0em;text-align:left;">Adjustment</p></th></tr></thead>
<tfoot>
<tr>
<td align="center" colspan="2">
<p style="text-indent:0em;text-align:left;">
<sup>a</sup> Some experts suggest a longer interval (8 weeks) after the invalid dose because of the potential for increased reactogenicity and rare risk of myocarditis and pericarditis; consider patient benefit versus risk.</p></td></tr>
<tr>
<td align="center" colspan="2">
<p style="text-indent:0em;text-align:left;">
<sup>b </sup>Unless patient experiences significant or prolonged adverse reactions (assess on a case-by-case basis).</p></td></tr></tfoot>
<tbody>
<tr>
<td align="center" colspan="2">
<p style="text-indent:0em;text-align:left;">
<i>
<b>Age</b></i></p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Person &lt;6 months of age received any COVID-19 vaccine product</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">If the first dose was administered ≥5 days before turning 6 months of age, repeat the dose when patient is ≥6 months of age.<sup>a</sup></p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Person 6 months to &lt;5 years of age received initial 2 doses with products from different manufacturers (ie, 1 dose from Moderna and 1 dose from Pfizer-BioNTech; any previous or current formulation).</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">Administer an age-appropriate third dose of either 2023-2024 formulation Moderna or Pfizer-BioNTech COVID-19 mRNA vaccine ≥8 weeks after the second dose.</p></td></tr>
<tr>
<td align="center" colspan="2">
<p style="text-indent:0em;text-align:left;">
<b>
<i>Product and dosage</i></b></p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Dose too high (due to incorrect product or dosage administered, including dose volume too high)</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">Do not repeat dose; administer subsequent dose at appropriate interval.<sup>b</sup></p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Dose too low (due to incorrect product or dosage administered, including dose volume too low)</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">Repeat dose immediately (no minimum interval) with age-appropriate product and dosage.<sup>a</sup></p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Half-dose volume or formulation administered inadvertently</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">If same clinic day, administer another half dose (2 doses counted as full dose). If different day, repeat dose.</p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Bivalent mRNA COVID-19 vaccine (Original and Omicron BA.4/5) administered instead of 2023-2024 Formula</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">Repeat dose using age-appropriate updated 2023-2024 formulation mRNA COVID-19 vaccine. If dose given in error was the first dose, then administer repeat dose ≥4 weeks later.<sup>a</sup> For other doses, administer repeat dose by at least the minimum interval.</p></td></tr>
<tr>
<td align="center" colspan="2">
<p style="text-indent:0em;text-align:left;">
<b>
<i>Dosing interval</i></b></p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Any COVID-19 dose administered prior to the minimum interval</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">Repeat dose at the minimum recommended interval from dose given in error (see dosing tables).<sup>a</sup></p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Any COVID-19 vaccine dose administered after recommended interval</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">Do not repeat dose; no maximum interval.</p></td></tr>
<tr>
<td align="center" colspan="2">
<p style="text-indent:0em;text-align:left;">
<b>
<i>Preparation (Pfizer-BioNTech products only)</i></b></p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Only diluent administered</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">Administer the authorized dose immediately with no minimum interval.</p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Inappropriate dilution resultant in lower than authorized dose</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">Repeat dose immediately (no minimum interval).<sup>a</sup></p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Dose undiluted or inappropriate dilution resulted in higher-than-authorized dose</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">Do not repeat dose.</p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Wrong diluent use</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">Contact manufacturer; if no stability data, repeat dose immediately (no minimum interval).</p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Diluent from single-use vial used for multiple vials</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">Do not repeat dose.</p></td></tr>
<tr>
<td align="center" colspan="2">
<p style="text-indent:0em;text-align:left;">
<b>
<i>Storage</i></b></p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;text-align:left;">Improper storage or handling of vaccine (eg, temperature excursion, dose administered past expiration date)</p></td>
<td align="center">
<p style="text-indent:0em;text-align:left;">Contact manufacturer; if no stability data, repeat dose immediately (no minimum interval).<sup>a</sup></p></td></tr></tbody></table></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F55187088"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F55187089"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doa drugH1Div" id="F55187213"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="130318" href="/d/html/130318.html" rel="external">see "COVID-19 mRNA vaccines: Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="1816035d-6a14-4ee1-9e09-06e166640b6c">COVID-19 prevention</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>COVID-19 prevention: </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> The only mRNA COVID-19 vaccines approved for use in the United States are based on the SARS-CoV-2 Omicron variant XBB.1.5 and labeled "2023-2024 Formula." EUA is no longer available for previous formulations (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-FDA.13','lexi-content-ref-FDA.14']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-FDA.13','lexi-content-ref-FDA.14'])">Ref</a></span>).</p>
<table border="1" frame="border" rules="all" style="margin-left:2em;">
<caption style="text-align:left;">
<b>COVID-19 Vaccine (mRNA) 2023-2024 Formulation Dose Recommendations for Patients ≥18 Years of Age WITHOUT Moderate to Severe Immunocompromising Conditions or Treatment (CDC 2023)</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead valign="middle">
<tr>
<th align="left">
<p style="text-indent:0em;">
<b>Manufacturer</b></p></th>
<th align="left">
<p style="text-indent:0em;">
<b>COVID-19 mRNA vaccine history (prior to 2023-2024 formulation)</b></p></th>
<th align="left">
<p style="text-indent:0em;">
<b>Vial description</b></p></th>
<th align="left">
<p style="text-indent:0em;">
<b>Total amount of mRNA per dose</b></p></th>
<th align="left">
<p style="text-indent:0em;">
<b>Number of 2023-2024 formulation doses indicated (administer IM)</b></p></th>
<th align="left">
<p style="text-indent:0em;">
<b>Interval between doses</b></p></th></tr></thead>
<tbody valign="middle">
<tr>
<td align="left" rowspan="2">
<p style="text-indent:0em;">Moderna products</p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">50 mcg per 0.5 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥1 dose of any previous COVID-19 vaccine formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">50 mcg per 0.5 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">Administer the 2023-2024 formulation dose ≥8 weeks after the last dose of previous formulation.</p></td></tr>
<tr>
<td align="left" rowspan="2">
<p style="text-indent:0em;">Pfizer-BioNTech products</p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Gray label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">30 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥1 dose of any previous COVID-19 vaccine formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Gray label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">30 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose</p></td>
<td align="left">
<p style="text-indent:0em;">Administer the 2023-2024 formulation dose ≥8 weeks after the last dose of previous formulation.</p></td></tr></tbody></table>
<table border="1" frame="border" rules="all">
<caption style="text-align:left;">
<b>COVID-19 Vaccine (mRNA) 2023-2024 Formulation Dose Recommendations for Patients ≥18 Years of Age WITH Moderate to Severe Immunocompromising Conditions or Treatment (CDC 2023) </b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead valign="middle">
<tr>
<th align="left">
<p style="text-indent:0em;">
<b>Manufacturer</b></p></th>
<th align="left">
<p style="text-indent:0em;">
<b>COVID-19 mRNA vaccine history (prior to 2023-2024 formulation)</b></p></th>
<th align="left">
<p style="text-indent:0em;">
<b>Vial description</b></p></th>
<th align="left">
<p style="text-indent:0em;">
<b>Total amount of mRNA per dose</b></p></th>
<th align="left">
<p style="text-indent:0em;">
<b>Number of 2023-2024 formulation doses indicated (administer IM)</b></p></th>
<th align="left">
<p style="text-indent:0em;">
<b>Interval between doses</b></p></th></tr></thead>
<tfoot valign="top">
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup> a</sup> Persons ≥18 years of age who are moderately or severely immunocompromised may receive an additional age-appropriate dose of a 2023-2024 formulation mRNA vaccine ≥2 months following the last recommended 2023-2024 formulation mRNA COVID-19 dose. Further additional doses may be administered, informed by the clinical judgment of a health care provider and personal preference and circumstances, ≥2 months after the last COVID-19 vaccine dose.</p></td></tr>
<tr>
<td align="left" colspan="6">
<p style="text-indent:0em;">
<sup> b </sup>Initial 3-dose vaccination series should be from the same manufacturer if possible. A different age-appropriate COVID-19 vaccine may be administered in some circumstances (ie, same vaccine not available at the vaccination site at the time of the clinic visit, previous dose unknown, person would otherwise not receive a recommended vaccine dose, or person starts but is unable to complete a vaccination series with the same COVID-19 vaccine due to a contraindication).</p></td></tr></tfoot>
<tbody valign="middle">
<tr>
<td align="left" rowspan="5">
<p style="text-indent:0em;">Moderna products</p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">50 mcg per 0.5 mL</p></td>
<td align="left">
<p style="text-indent:0em;">3 doses<sup>a, b</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer second dose 4 weeks following the first dose, and administer the third dose ≥4 weeks after the second.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">1 dose of any previous Moderna formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">50 mcg per 0.5 mL</p></td>
<td align="left">
<p style="text-indent:0em;">2 doses<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer first dose 4 weeks following the dose of previous formulation, and administer second dose ≥4 weeks after the first 2023-2024 formulation.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">2 doses of any previous Moderna formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">50 mcg per 0.5 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer dose ≥4 weeks after last dose of previous formulation.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥3 doses of any previous mRNA COVID-19 vaccine formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">50 mcg per 0.5 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer dose ≥8 weeks after the last dose of previous formulation.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥1 dose of Novavax or Janssen, including in combination with any mRNA COVID-19 vaccine dose(s)</p></td>
<td align="left">
<p style="text-indent:0em;">Blue label and dark blue cap</p></td>
<td align="left">
<p style="text-indent:0em;">50 mcg per 0.5 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer dose ≥8 weeks after the last dose of previous formulation.</p></td></tr>
<tr>
<td align="left" rowspan="5">
<p style="text-indent:0em;">Pfizer-BioNTech products</p></td>
<td align="left">
<p style="text-indent:0em;">No prior COVID-19 vaccine</p></td>
<td align="left">
<p style="text-indent:0em;">Gray label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">30 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">3 doses<sup>a, b</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer second dose 3 weeks following the first dose, and administer third dose ≥4 weeks after the second.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">1 dose of any previous Pfizer-BioNTech formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Gray label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">30 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">2 doses<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer the first dose 3 weeks after the dose of previous formulation, and administer the second dose ≥4 weeks after the first 2023-2024 formulation dose.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">2 doses of any previous Pfizer-BioNTech formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Gray label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">30 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥4 weeks after the last dose of previous formulation.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥3 doses of any previous mRNA COVID-19 vaccine formulation</p></td>
<td align="left">
<p style="text-indent:0em;">Gray label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">30 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥8 weeks after the last dose of previous formulation.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">≥1 dose of Novavax or Janssen, including in combination with any mRNA COVID-19 vaccine dose(s)</p></td>
<td align="left">
<p style="text-indent:0em;">Gray label and cap</p></td>
<td align="left">
<p style="text-indent:0em;">30 mcg per 0.3 mL</p></td>
<td align="left">
<p style="text-indent:0em;">1 dose<sup>a</sup></p></td>
<td align="left">
<p style="text-indent:0em;">Administer the dose ≥8 weeks after the last dose of previous formulation.</p></td></tr></tbody></table>
<p style="text-indent:-2em;margin-left:4em;">
<i>Canadian and international recommendations:</i> Preparations of COVID-19 mRNA vaccines containing different components (eg, SARS-CoV-2 Original strain, Omicron BA.1, BA.4/BA.5, and XBB.1.5 variants) may be available. Recommendations related to use of these preparations and approved ages may vary per country; consult local product labeling. The Canadian National Advisory Committee on Immunization (NACI) provides different recommendations as compared to the CDC, including longer intervals; see NACI recommendations for details. The NACI recommends that beginning in Fall 2023, persons who were previously vaccinated against COVID-19 receive a dose of an age-appropriate XBB.1.5 variant-containing COVID-19 vaccine if it has been ≥6 months from the previous COVID-19 vaccine dose or known SARS-CoV-2 infection (whichever is later) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-NACI.1','lexi-content-ref-NACI.3','lexi-content-ref-NACI.4']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-NACI.1','lexi-content-ref-NACI.3','lexi-content-ref-NACI.4'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Revaccination: Note:</b> For patients who received ≥1 doses of COVID-19 vaccine prior to or while receiving a hematopoietic cell transplant (HCT) or chimeric antigen receptor (CAR)–T-cell therapy, revaccination is recommended; revaccinate when ≥3 months post HCT or CAR-T-cell therapy. In patients who received ≥1 doses of COVID-19 vaccine during treatment with B-cell–depleting therapies (eg, rituximab, ocrelizumab) that were administered over a limited period (eg, as part of a treatment regimen for certain malignancies), revaccination may be considered ~6 months after completion of B-cell–depleting therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.5']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.5'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Dosing recommendations for deviations in administration, preparation, or storage:</b></p>
<table border="1" frame="border" rules="all" style="margin-left:4em;">
<caption>
<b>Recommendations for Deviations in COVID-19 Vaccine Usage<sup>a</sup></b></caption>
<colgroup><col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;">Deviation</p></th>
<th align="left">
<p style="text-indent:0em;">Adjustment</p></th></tr></thead>
<tfoot>
<tr>
<td align="left" colspan="2">
<p style="text-indent:0em;">
<sup>a</sup> CDC 2023; refer to CDC guidance documents for additional information.</p></td></tr>
<tr>
<td align="left" colspan="2">
<p style="text-indent:0em;">
<sup>b</sup> Unless patient experiences significant or prolonged adverse reactions (assess on a case-by-case basis).</p></td></tr>
<tr>
<td align="left" colspan="2">
<p style="text-indent:0em;">
<sup>c</sup> A longer interval (8 weeks) after the invalid dose may be optimal for some patients because of the potential for increased reactogenicity and rare risk of myocarditis and pericarditis; consider patient benefit versus risk.</p></td></tr></tfoot>
<tbody>
<tr>
<td align="left" colspan="2">
<p style="text-indent:0em;">
<b>
<i>Product and dosage</i></b></p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">Dose too high (due to incorrect product or dosage administered, including dose volume too high)</p></td>
<td align="left">
<p style="text-indent:0em;">Do not repeat dose; administer subsequent dose(s) at appropriate interval(s).<sup>b</sup></p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">Dose too low (due to incorrect product or dosage administered, including dose volume too low)</p></td>
<td align="left">
<p style="text-indent:0em;">Repeat dose immediately (no minimum interval) with age-appropriate product and dosage.<sup>c</sup></p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">Half-dose volume or formulation administered inadvertently</p></td>
<td align="left">
<p style="text-indent:0em;">If same clinic day, administer another half dose (2 half doses counted as one full dose). If different day, administer full dose.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">Bivalent mRNA COVID-19 vaccine (Original and Omicron BA.4/5) administered instead of 2023-2024 formula</p></td>
<td align="left">
<p style="text-indent:0em;">Repeat dose using age-appropriate updated 2023-2024 formulation mRNA COVID-19 vaccine. If dose given in error was the first dose, then administer repeat dose ≥4 weeks later.<sup>c</sup> For other doses, administer repeat dose by at least the minimum interval.</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">2023-2024 formulation COVID-19 vaccines from different manufacturers inadvertently administered as part of a 2- or 3-dose initial vaccination series</p></td>
<td align="left">
<p style="text-indent:0em;">No further doses needed for persons not moderately or severely immunocompromised.</p>
<p style="text-indent:0em;">If moderately or severely immunocompromised, administer 1 dose of any COVID-19 vaccine (2023-2024 formulation) ≥4 weeks after the last dose (total of 3 doses).</p></td></tr>
<tr>
<td align="left" colspan="2">
<p style="text-indent:0em;">
<b>
<i>Dosing interval</i></b></p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">Dose administered too early (ie, more than 4 days prior to the recommended interval)</p></td>
<td align="left">
<p style="text-indent:0em;">Repeat dose at the minimum recommended interval from dose given in error.<sup>c</sup></p></td></tr>
<tr>
<td align="left" colspan="2">
<p style="text-indent:0em;">
<b>
<i>Storage</i></b></p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">Improper storage or handling of vaccine (eg, temperature excursion, dose administered past expiration date)</p></td>
<td align="left">
<p style="text-indent:0em;">Contact manufacturer; if no stability data, repeat dose immediately (no minimum interval).<sup>c</sup></p></td></tr></tbody></table></div>
</div>
</div>
<div class="block dora drugH1Div" id="F55187215"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F55187216"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block arsc drugH1Div" id="F55189490"><span class="drugH1">Adverse Reactions (Significant): Considerations</span>
<div class="collapsible">
<span class="collapsible-title">Hypersensitivity reactions</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Severe hypersensitivity reactions</b>, including <b>anaphylaxis</b>, have been reported with both the Pfizer-BioNTech (Comirnaty) and Moderna (Spikevax) COVID-19 Vaccines (mRNA) during vaccination outside of clinical trials (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.1','lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.1','lexi-content-ref-CDC.2'])">Ref</a></span>). Other hypersensitivity reactions that were commonly present with anaphylaxis included <b>airway obstruction</b>, <b>angioedema</b>, <b>nausea</b>, <b>pruritus</b>, <b>skin rash</b>, and <b>urticaria</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33576785']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33576785'])">Ref</a></span>). Immediate treatment (including epinephrine 1 mg/mL) for anaphylactoid and/or hypersensitivity reactions should be available during vaccine administration (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Kroger.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Kroger.2'])">Ref</a></span>). Of importance, the polyethylene glycol (PEG) excipient in the COVID-19 mRNA vaccines was initially suspected to be the cause of severe hypersensitivity reactions; however, several case series have documented no severe reactions with COVID-19 mRNA vaccination in patients with known or probable PEG or polysorbate allergy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34153517','lexi-content-ref-34678498','lexi-content-ref-34398511','lexi-content-ref-35288274','lexi-content-ref-34949564']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34153517','lexi-content-ref-34678498','lexi-content-ref-34398511','lexi-content-ref-35288274','lexi-content-ref-34949564'])">Ref</a></span>). Data also suggest an association between the booster dose of COVID-19 mRNA vaccination, particularly Moderna, and the risk of new-onset chronic spontaneous urticaria (CSU) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-36723944']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-36723944'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Onset: </i>Anaphylaxis<i>: </i>Rapid; Pfizer: Median onset 10 minutes (range: &lt;1 minute to 19 hours) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33576785']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33576785'])">Ref</a></span>). Moderna: Median onset 10 minutes (range: 1 to 45 minutes) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33576785']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33576785'])">Ref</a></span>). CSU: Intermediate; Median onset 10 to 11 days (range: 8 to 13 days) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-36723944']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-36723944'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Risk factors:</i></p>
<p style="text-indent:-2em;margin-left:6em;">Precautions (<b>but not contraindications</b>) include:</p>
<p style="text-indent:-2em;margin-left:8em;">• History of any non-severe, immediate (onset &lt;4 hours) allergic reaction to a previous dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:8em;">• A history of anaphylaxis to any other vaccine or injectable therapy (eg, IM, IV, or SubQ vaccines or therapies [excluding SubQ immunotherapy for allergies]) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:8em;">• Patients with an allergy-related contraindication to another type of COVID-19 vaccine (eg, adenovirus vector) (certain measures must be taken before a different type of COVID-19 [eg, mRNA] is administered to these patients) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2'])">Ref</a></span>)</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Local reactions</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:2em;">Local reactions occur in both adult and pediatric patients (ages ≥6 months) and include <b>erythema at injection site, pain at injection site</b>, and <b>swelling at injection site</b>. In the adult population, injection site pain was reported more frequently in patients 16 to 55 years of age and was more likely to be moderate in severity compared to patients ≥56 years with the Pfizer-BioNTech (Comirnaty) COVID-19 Vaccine (mRNA) primary series. Similarly, injection site pain was reported more frequently in patients 18 to 64 years of age with the Moderna (Spikevax) COVID-19 Vaccine (mRNA). Local reactions were similar to the primary series for the Pfizer-BioNTech COVID-19 Vaccine (mRNA) and the Moderna (Spikevax) COVID-19 Vaccine (mRNA) monovalent and bivalent booster doses. In general, local reactions were mild to moderate in severity and resolved after a mean duration of ~2 to 3 days in both adult and pediatric patients. The proportion of local reactions did not increase after the second dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33301246']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33301246'])">Ref</a></span>). Local <b>hypersensitivity reactions</b> (including <b>rash at injection site </b>and <b>urticaria at injection site</b>) have occurred with the Moderna (Spikevax) COVID-19 Vaccine (mRNA). Swelling at or near the site of dermal fillers (eg, face or lips) may also occur (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Delayed-onset <b>injection-site reactions</b> (“COVID arm”) have occurred with the Moderna (Spikevax) COVID-19 Vaccine (mRNA) and include erythema, induration, swelling, pain/tenderness, and pruritus (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33657292','lexi-content-ref-33978670']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33657292','lexi-content-ref-33978670'])">Ref</a></span>). Delayed-onset local reactions that occur with the first dose are not a contraindication or precaution to the second dose; administer the same vaccine but preferably in the opposite arm (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33657292']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33657292'])">Ref</a></span>). Delayed-onset local reactions resolved after a median duration of 4 to 6 days (range: 2 to 11 days) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33657292','lexi-content-ref-33978670']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33657292','lexi-content-ref-33978670'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Mechanism: </i>Delayed-onset local reactions: Non–dose-related; immunologic (T-cell mediated) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33978670']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33978670'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Onset: </i>Varied. Local reactions occur within 7 days after either injection (typically within ~1 day) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33978670','lexi-content-ref-33301246']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33978670','lexi-content-ref-33301246'])">Ref</a></span>). Delayed-onset local reactions occur with a median onset on day 7 or 8 after the first dose (range: 2 to 12 days) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33657292','lexi-content-ref-33978670']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33657292','lexi-content-ref-33978670'])">Ref</a></span>). For patients who experienced delayed-onset local reactions with the first dose, delayed-onset local reactions occur more quickly with the second dose with a median onset on day 2 after the second dose (range: 0 to 5 days) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33657292','lexi-content-ref-33978670']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33657292','lexi-content-ref-33978670'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Myocarditis and pericarditis</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Myocarditis</b> and <b>pericarditis</b> have been reported rarely with both the Pfizer-BioNTech (Comirnaty) and Moderna (Spikevax) COVID-19 Vaccines (mRNA) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2'])">Ref</a></span>). Evidence suggests a possible higher risk for myocarditis with the Moderna COVID-19 Vaccine (mRNA) versus the Pfizer-BioNTech (Comirnaty) Vaccine (mRNA) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2'])">Ref</a></span>). The risk of myocarditis after a booster dose may be similar to or lower than the risk after the second dose of the primary series for the Pfizer-BioNTech COVID-19 and Moderna COVID-19 Vaccines (mRNA) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2'])">Ref</a></span>). Symptoms may include acute chest pain, shortness of breath, or palpitations; younger children may also experience <b>irritability</b>, lethargy, poor feeding, and tachypnea (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.4','lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.4','lexi-content-ref-CDC.2'])">Ref</a></span>). Most cases resolved with hospitalization, treatment, and rest within 90 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.4','lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.4','lexi-content-ref-CDC.2'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Mechanism: </i>Unknown; various immune and non-immune hypotheses exist (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-35830976']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-35830976'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Onset:</i> Varied; usually within 7 days (most often 2 to 4 days) after the second dose or booster dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.4','lexi-content-ref-CDC.2','lexi-content-ref-35830976']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.4','lexi-content-ref-CDC.2','lexi-content-ref-35830976'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Risk factors: </i></p>
<p style="text-indent:-2em;margin-left:6em;">• Males &lt;40 years of age (median age of 20 to 30 years of age in most cases) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-FDA.2','lexi-content-ref-FDA.3','lexi-content-ref-35830976']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-FDA.2','lexi-content-ref-FDA.3','lexi-content-ref-35830976'])">Ref</a></span>)</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Systemic reactions (excluding hypersensitivity)</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:2em;">Systemic reactions occur in both adult and pediatric patients (ages ≥6 months) and include <b>arthralgia</b>, <b>chills</b>, <b>diarrhea</b>, <b>fatigue, fever, headache, myalgia, nausea, and vomiting</b>. Younger children, especially those &lt;3 years of age, may also experience <b>irritability</b>/crying, <b>drowsiness</b>, and <b>decreased appetite</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2'])">Ref</a></span>). In both adult and pediatric patients in general, the frequency and severity of systemic reactions were higher after the second dose with the Pfizer-BioNTech (Comirnaty) COVID-19 Vaccine (mRNA) primary series. In the adult population, frequency and severity of systemic reactions were also higher in patients 16 to 55 years of age than patients ≥56 years with the primary series. Similarly, the frequency and severity of systemic reactions were higher after the second dose and in patients 18 to 64 years of age with the Moderna (Spikevax) COVID-19 Vaccine (mRNA). Systemic reactions were similar to the primary series for the Pfizer-BioNTech COVID-19 Vaccine (mRNA) and the Moderna COVID-19 Vaccine (mRNA) monovalent and bivalent booster doses. Most systemic reactions were mild to moderate in severity and resolved within 1 to 3 days of onset (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2'])">Ref</a></span>). Reactions (eg, chills, fever, myalgia) may occur more frequently with the first dose in patients with prior SARS-CoV-2 infection (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2'])">Ref</a></span>). An unsolicited systemic reaction possibly attributed to vaccine was <b>lymphadenopathy</b>.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Onset: </i>Rapid; within 3 days after either injection (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2'])">Ref</a></span>)</p></div>
</div>
</div>
<div class="block adr drugH1Div" id="F55189491"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse reactions and incidences are derived from product labeling and the FDA issued emergency use authorizations (EUAs) for the Pfizer BioNTech COVID-19 Vaccine mRNA (Comirnaty) (ages ≥6 months) (primary series, monovalent booster doses, and bivalent booster doses), and the Moderna COVID-19 Vaccine (Spikevax) (ages ≥6 months) (primary series, monovalent booster doses, and bivalent booster doses), unless otherwise specified. Refer to product labeling and EUAs for specific vaccines for information regarding reporting adverse reactions (FDA 2022b, FDA 2022c, FDA 2022d, FDA 2022i, FDA 2022j).</p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Decreased appetite (infants and children: 5% to 32%)<span class="lexi-table-link-container"> (<a aria-label="Decreased Appetite table link" class="lexi-table-link" data-table-id="lexi-content-decreased-appetite" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-decreased-appetite')">table 1</a>)</span><span class="table-link" style="display:none;">Decreased Appetite</span>, diarrhea (Pfizer: 4% to 11%)<span class="lexi-table-link-container"> (<a aria-label="Diarrhea table link" class="lexi-table-link" data-table-id="lexi-content-diarrhea" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-diarrhea')">table 2</a>)</span><span class="table-link" style="display:none;">Diarrhea</span>, nausea and vomiting (Moderna: 4% to 24%)<span class="lexi-table-link-container"> (<a aria-label="Nausea and Vomiting table link" class="lexi-table-link" data-table-id="lexi-content-nausea-and-vomiting" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-nausea-and-vomiting')">table 3</a>)</span><span class="table-link" style="display:none;">Nausea and Vomiting</span></p>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Decreased Appetite" frame="border" id="lexi-content-decreased-appetite" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Decreased Appetite</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">30%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">26%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,746</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">582</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">32%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">25%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,596</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">526</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">24%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">22%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">944</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">320</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">31%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">21%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">963</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">330</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">23%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">17 months to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">120</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">22%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">21%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,159 to 1,173</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">591 to 595</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">22%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,137 to 1,147</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">590 to 591</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">20%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">14%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">362 to 365</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">170</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">5%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;">24</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr></tbody></table>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Diarrhea" frame="border" id="lexi-content-diarrhea" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Diarrhea</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,813 to 1,824</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">905 to 909</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,772 to 1,779</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">877 to 878</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">547 to 552</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">262</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">6%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">36</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,511</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,501</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">740</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">371</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,097</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,078</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,899</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,908</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">10%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,682</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,684</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">289</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,008</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,989</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,860</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,833</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">298</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">301</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr></tbody></table>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Nausea and Vomiting" frame="border" id="lexi-content-nausea-and-vomiting" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Nausea and Vomiting</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,013</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">650</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">10%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,975</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">629</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">4%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">25</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,004</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">993</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">24%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,988</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">969</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">13%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,280</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,482</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,238</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">24%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,478</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,220</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">18%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,312</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,406</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,407</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">21%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,985</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,918</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">129</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">13%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">211</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">13%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">263</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,762</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,692</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,648</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">38</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">140</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">174</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr></tbody></table>
<p style="text-indent:-2em;margin-left:4em;">Local: Erythema at injection site (2% to 20%)<span class="lexi-table-link-container"> (<a aria-label="Erythema at Injection Site table link" class="lexi-table-link" data-table-id="lexi-content-erythema-at-injection-site" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-erythema-at-injection-site')">table 4</a>)</span><span class="table-link" style="display:none;">Erythema at Injection Site</span>, pain at injection site (27% to 95%)<span class="lexi-table-link-container"> (<a aria-label="Pain at Injection Site table link" class="lexi-table-link" data-table-id="lexi-content-pain-at-injection-site" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-pain-at-injection-site')">table 5</a>)</span><span class="table-link" style="display:none;">Pain at Injection Site</span>, swelling at injection site (3% to 21%)<span class="lexi-table-link-container"> (<a aria-label="Swelling at Injection Site table link" class="lexi-table-link" data-table-id="lexi-content-swelling-at-injection-site" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-swelling-at-injection-site')">table 6</a>)</span><span class="table-link" style="display:none;">Swelling at Injection Site</span>, tenderness at injection site (infants and children: Pfizer: 4% to 17%)<span class="lexi-table-link-container"> (<a aria-label="Tenderness at Injection Site table link" class="lexi-table-link" data-table-id="lexi-content-tenderness-at-injection-site" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-tenderness-at-injection-site')">table 7</a>)</span><span class="table-link" style="display:none;">Tenderness at Injection Site</span></p>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Erythema at Injection Site" frame="border" id="lexi-content-erythema-at-injection-site" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Erythema at Injection Site</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,746</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">582</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">14%</p></td>
<td align="left">
<p style="text-indent:0em;">4%</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,596</p></td>
<td align="left">
<p style="text-indent:0em;">526</p></td>
<td align="left">
<p style="text-indent:0em;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">10%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">944</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">320</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">963</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">330</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">11%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">17 months to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">120</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,013</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">650</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,975</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">629</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">4%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">25</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,004</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">993</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">19%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,988</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">969</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">11%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,280</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">14%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,482</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,238</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">20%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,478</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,220</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">9%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,312</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,406</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,407</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,985</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,918</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">129</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">211</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">263</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,762</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,692</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,648</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">38</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">140</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">174</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,159 to 1,173</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">591 to 595</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,137 to 1,147</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">590 to 591</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">362 to 365</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">170</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">8%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;">24</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,814 to 1,825</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">905 to 909</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,772 to 1,779</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">877 to 878</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">547 to 552</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">262</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">8%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">36</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">15%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,511</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">19%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,501</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">740</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">16%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">371</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,097</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,078</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,899</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,908</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,682</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,684</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">289</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,008</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,989</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,860</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,833</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">298</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">301</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr></tbody></table>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Pain at Injection Site" frame="border" id="lexi-content-pain-at-injection-site" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Pain at Injection Site</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">37%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">30%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,746</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">582</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">46%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">26%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,596</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">526</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">53%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">944</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">320</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">68%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">44%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">963</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">330</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">42%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">17 months to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">120</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">65%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">41%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,013</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">650</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">73%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">40%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,975</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">629</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">56%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">25</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">93%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">47%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,004</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">993</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">95%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">50%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,988</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">969</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">90%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,280</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">93%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">35%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,482</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,238</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">93%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">30%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,478</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,220</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">91%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,312</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">87%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">19%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,406</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,407</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">90%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">19%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,985</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,918</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">86%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">129</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">83%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">211</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">88%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">263</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">74%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">13%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,762</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">83%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,692</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,648</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">76%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">38</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">67%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">140</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">62%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">174</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">31%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">21%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,814 to 1,825</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">905 to 909</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">31%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">20%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,772 to 1,779</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">877 to 878</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">27%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">13%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">547 to 552</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">262</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">28%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">36</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">74%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">31%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,511</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">71%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">30%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,501</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">740</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">74%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">371</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">86%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">23%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">79%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,097</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,078</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">84%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">14%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,899</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,908</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">78%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,682</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,684</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">83%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">289</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">70%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,008</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,989</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">66%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,860</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,833</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">60%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">298</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">58%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">301</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr></tbody></table>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Swelling at Injection Site" frame="border" id="lexi-content-swelling-at-injection-site" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Swelling at Injection Site</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,746</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">582</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">15%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,596</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">526</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">944</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">320</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">963</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">330</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">11%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">17 months to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">120</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,013</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">650</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,975</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">629</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">12%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">25</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,004</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">993</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">17%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,988</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">969</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">11%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,280</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">16%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,482</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,238</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">21%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,478</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,220</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">13%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,312</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,406</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,407</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">13%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,985</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,918</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">129</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">211</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">263</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,762</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,692</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,648</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">38</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">140</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">174</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,159 to 1,173</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">591 to 595</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,137 to 1,147</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">590 to 591</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">362 to 365</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">170</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">4%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;">24</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,814 to 1,825</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">905 to 909</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,772 to 1,779</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">877 to 878</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">547 to 552</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">262</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">3%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">36</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,511</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">15%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,501</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">740</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">16%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">371</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,097</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,078</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,899</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,908</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,682</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,684</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">289</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,008</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,989</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,860</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,833</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">298</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">301</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr></tbody></table>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Tenderness at Injection Site" frame="border" id="lexi-content-tenderness-at-injection-site" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Tenderness at Injection Site</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">17%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,159 to 1,173</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">591 to 595</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">15%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,137 to 1,147</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">590 to 591</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">16%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">362 to 365</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">170</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">4%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;">24</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr></tbody></table>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Chills (2% to 49%)<span class="lexi-table-link-container"> (<a aria-label="Chills table link" class="lexi-table-link" data-table-id="lexi-content-chills" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-chills')">table 8</a>)</span><span class="table-link" style="display:none;">Chills</span>, drowsiness (infants and children: 9% to 37%)<span class="lexi-table-link-container"> (<a aria-label="Drowsiness table link" class="lexi-table-link" data-table-id="lexi-content-drowsiness" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-drowsiness')">table 9</a>)</span><span class="table-link" style="display:none;">Drowsiness</span>, fatigue (25% to 68%)<span class="lexi-table-link-container"> (<a aria-label="Fatigue table link" class="lexi-table-link" data-table-id="lexi-content-fatigue" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-fatigue')">table 10</a>)</span><span class="table-link" style="display:none;">Fatigue</span>, headache (3% to 70%)<span class="lexi-table-link-container"> (<a aria-label="Headache table link" class="lexi-table-link" data-table-id="lexi-content-headache" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-headache')">table 11</a>)</span><span class="table-link" style="display:none;">Headache</span>, irritability (and/or crying; infants and children: 18% to 68%)<span class="lexi-table-link-container"> (<a aria-label="Irritability table link" class="lexi-table-link" data-table-id="lexi-content-irritability" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-irritability')">table 12</a>)</span><span class="table-link" style="display:none;">Irritability</span></p>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Chills" frame="border" id="lexi-content-chills" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Chills</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,013</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">650</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,975</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">629</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">8%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">25</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">10%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,004</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">993</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">30%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,988</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">969</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">14%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,280</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">18%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,482</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,238</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">43%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,478</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,220</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">30%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,312</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,406</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,407</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">49%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,985</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,918</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">40%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">129</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">26%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">211</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">24%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">263</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,762</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">31%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,692</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,648</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">18%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">38</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">14%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">140</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">23%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">174</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,813 to 1,824</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">905 to 909</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,772 to 1,779</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">877 to 878</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">547 to 552</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">262</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">3%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">36</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,511</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">10%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,501</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">740</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">371</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">28%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">42%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,097</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,078</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">17%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,899</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,908</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">38%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,682</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,684</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">29%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">289</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,008</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,989</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">23%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,860</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,833</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">16%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">298</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">13%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">301</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr></tbody></table>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Drowsiness" frame="border" id="lexi-content-drowsiness" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Drowsiness</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">37%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,746</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">582</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">35%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">33%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,596</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">526</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">30%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">29%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">944</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">320</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">36%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">27%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">963</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">330</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">27%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">17 months to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">120</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">27%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">29%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,159 to 1,173</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">591 to 595</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">24%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">21%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,137 to 1,147</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">590 to 591</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">20%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">13%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">362 to 365</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">170</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">9%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;">24</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr></tbody></table>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Fatigue" frame="border" id="lexi-content-fatigue" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Fatigue</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">40%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">36%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,013</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">650</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">48%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">29%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,975</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">629</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">32%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">25</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">43%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">34%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,004</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">993</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">65%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">35%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,988</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">969</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">49%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,280</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">48%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,482</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,238</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">68%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">29%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,478</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,220</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">59%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,312</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">39%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">29%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,406</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,407</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">68%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">25%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,985</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,918</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">62%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">129</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">55%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">211</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">59%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">263</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">33%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">23%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,762</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">58%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">20%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,692</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,648</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">47%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">38</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">47%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">140</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">49%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">174</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">30%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">31%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,813 to 1,824</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">905 to 909</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">26%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">23%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,772 to 1,779</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">877 to 878</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">25%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">22%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">547 to 552</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">262</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">31%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">36</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">34%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">31%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,511</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">39%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">24%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,501</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">740</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">46%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">371</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">60%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">41%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">66%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">25%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,097</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,078</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">49%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">33%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,899</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,908</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">62%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">23%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,682</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,684</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">64%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">289</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">34%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">23%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,008</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,989</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">51%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">17%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,860</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,833</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">45%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">298</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">49%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">301</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr></tbody></table>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Headache" frame="border" id="lexi-content-headache" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Headache</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,013</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">650</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">16%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,975</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">629</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">20%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">25</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">31%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">31%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,004</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">993</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">54%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">28%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,988</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">969</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">38%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,280</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">45%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">39%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,482</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,238</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">70%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">30%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,478</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,220</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">57%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,312</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">35%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">29%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,406</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,407</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">63%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">25%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,985</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,918</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">59%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">129</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">47%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">211</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">49%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">263</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">25%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">19%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,762</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">46%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,692</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,648</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">42%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">38</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">32%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">140</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">36%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">174</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,813 to 1,824</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">905 to 909</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,772 to 1,779</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">877 to 878</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">547 to 552</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">262</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">3%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">36</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">22%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">24%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,511</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">28%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">19%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,501</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">740</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">34%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">371</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">55%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">35%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">65%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">24%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,097</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,078</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">44%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">34%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,899</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,908</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">54%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">24%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,682</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,684</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">48%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">289</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">25%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,008</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,989</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">39%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">14%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,860</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,833</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">27%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">298</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">34%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">301</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr></tbody></table>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Irritability" frame="border" id="lexi-content-irritability" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Irritability</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">68%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">62%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,746</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">582</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td>
<td align="left" rowspan="5">
<p style="text-indent:0em;text-align:left;">Described as "irritability/crying"</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">64%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">59%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,596</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">526</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">55%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">51%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">944</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">320</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">54%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">45%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">963</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">330</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">53%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">17 months to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">120</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">51%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">47%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,159 to 1,173</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">591 to 595</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td>
<td align="left" rowspan="4">
<p style="text-indent:0em;text-align:left;">N/A</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">47%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">41%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,137 to 1,147</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">590 to 591</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">44%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">38%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">362 to 365</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">170</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">18%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;">24</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr></tbody></table>
<p style="text-indent:-2em;margin-left:4em;">Neuromuscular &amp; skeletal: Arthralgia (Moderna: 6% to 46%; Pfizer: ≤25%)<span class="lexi-table-link-container"> (<a aria-label="Arthralgia table link" class="lexi-table-link" data-table-id="lexi-content-arthralgia" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-arthralgia')">table 13</a>)</span><span class="table-link" style="display:none;">Arthralgia</span>, axillary swelling (Moderna: Including axillary tenderness; 4% to 28%), myalgia (Moderna: 10% to 62%; Pfizer: 2% to 39%)<span class="lexi-table-link-container"> (<a aria-label="Myalgia table link" class="lexi-table-link" data-table-id="lexi-content-myalgia" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-myalgia')">table 14</a>)</span><span class="table-link" style="display:none;">Myalgia</span></p>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Arthralgia" frame="border" id="lexi-content-arthralgia" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Arthralgia</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,013</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">650</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,975</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">629</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">8%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">25</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,004</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">993</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">16%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,988</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">969</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">13%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,280</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">15%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,482</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,238</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">29%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,478</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,220</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">24%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">1,312</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">17%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,406</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,407</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">46%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,985</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,918</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">42%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">129</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">33%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">211</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">33%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">263</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">16%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,762</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">35%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,692</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,648</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">40%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">38</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">30%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">140</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">28%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">174</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,813 to 1,824</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">905 to 909</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,772 to 1,779</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">877 to 878</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">547 to 552</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">262</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">3%</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;">36</p></td>
<td align="left">
<p style="text-indent:0em;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,511</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,501</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">740</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">371</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">10%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">16%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,097</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,078</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,899</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,908</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">24%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,682</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,684</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">25%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">289</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,008</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,989</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">19%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,860</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,833</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">298</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">301</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr></tbody></table>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Myalgia" frame="border" id="lexi-content-myalgia" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Myalgia</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">10%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,013</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">650</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">16%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,975</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">629</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">25</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">15%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,004</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">993</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">28%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,988</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">969</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">21%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,280</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">27%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">17%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,482</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,238</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">47%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">13%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,478</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,220</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">40%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,312</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">24%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">14%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,406</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,407</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">62%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">13%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,985</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,918</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">50%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">129</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">43%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">211</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">43%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">263</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">20%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,762</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">47%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,692</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,648</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">47%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">38</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">32%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">140</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">35%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">174</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,813 to 1,824</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">905 to 909</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,772 to 1,779</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">877 to 878</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">547 to 552</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">262</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,511</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,501</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">740</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">18%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">371</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">24%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">13%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">32%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,097</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,078</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">23%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,899</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,908</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">39%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,682</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,684</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">39%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">289</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">14%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,008</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,989</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">29%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,860</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,833</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">20%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">298</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">22%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">301</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr></tbody></table>
<p style="text-indent:-2em;margin-left:4em;">Miscellaneous: Fever (≤24%)<span class="lexi-table-link-container"> (<a aria-label="Fever table link" class="lexi-table-link" data-table-id="lexi-content-fever" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-fever')">table 15</a>)</span><span class="table-link" style="display:none;">Fever</span></p>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Fever" frame="border" id="lexi-content-fever" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Fever</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,746</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">582</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">15%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,596</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">526</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">944</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">320</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">19%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">963</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">330</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">10%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">17 months to 3 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">120</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,013</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">650</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">16%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,975</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">629</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">37 months to 5 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">25</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,004</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">993</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">24%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,988</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">969</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,280</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,482</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,238</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,478</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,220</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,312</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,406</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">11,407</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">17%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,985</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">10,918</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">129</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">211</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 64 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">263</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,762</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">10%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,692</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3,648</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">38</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">140</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥65 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">174</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,159 to 1,173</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">591 to 595</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,137 to 1,147</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">590 to 591</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">362 to 365</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">170</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">24</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,813 to 1,824</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">905 to 909</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,772 to 1,779</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">877 to 878</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">547 to 552</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">262</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,511</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,501</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">740</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">371</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">10%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">20%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,097</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,078</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,899</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,908</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">16%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,682</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,684</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">289</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,008</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,989</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">12%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,860</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,833</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">298</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">301</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr></tbody></table>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Abdominal pain (Moderna: 1%), nausea (Pfizer: ≤1%), vomiting (Pfizer: ≤3%)<span class="lexi-table-link-container"> (<a aria-label="Vomiting table link" class="lexi-table-link" data-table-id="lexi-content-vomiting" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-vomiting')">table 16</a>)</span><span class="table-link" style="display:none;">Vomiting</span></p>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Vomiting" frame="border" id="lexi-content-vomiting" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Vomiting</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Number of Patients (Placebo)</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Comments</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,813 to 1,824</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">905 to 909</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,772 to 1,779</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">877 to 878</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">547 to 552</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">262</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 3</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2 to 4 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">36</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,511</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">748</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.8%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,501</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">740</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">371</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.9%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,127</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 15 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,097</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,078</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,899</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,908</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">16 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,682</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,684</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">18 to 55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">289</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2,008</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,989</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 1</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.7%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥56 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,860</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1,833</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Dose 2</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">298</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Monovalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">&gt;55 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">301</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">N/A</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Bivalent booster dose</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Pfizer</p></td></tr></tbody></table>
<p style="text-indent:-2em;margin-left:4em;">Hematologic &amp; oncologic: Lymphadenopathy (≤5%; unsolicited)</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Hypersensitivity reaction (Moderna: 2% to 5%; including rash at injection site, urticaria at injection site, and severe hypersensitivity reaction)<span class="lexi-table-link-container"> (<a aria-label="Hypersensitivity Reaction table link" class="lexi-table-link" data-table-id="lexi-content-hypersensitivity-reaction" onclick="event.preventDefault(); window.mobileShowLexiTable &amp;&amp; mobileShowLexiTable('lexi-content-hypersensitivity-reaction')">table 17</a>)</span><span class="table-link" style="display:none;">Hypersensitivity Reaction</span></p>
<table border="1" class="lexi-modal-content" data-hyperlink="yes" data-table-id="Hypersensitivity Reaction" frame="border" id="lexi-content-hypersensitivity-reaction" rules="all">
<caption style="text-align:center;">
<b>COVID-19 Vaccine (mRNA): Adverse Reaction: Hypersensitivity Reaction</b></caption>
<colgroup><col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup><thead>
<tr>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Drug (COVID-19 Vaccine [mRNA])</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Placebo </b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Population</b></p></th>
<th align="left">
<p style="text-indent:0em;text-align:left;">
<b>Manufacturer</b></p></th></tr></thead>
<tbody>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 23 months of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">4%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">5%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">3%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">6 to 11 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">0.6%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">12 to 17 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;text-align:left;">2%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">1%</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">≥18 years of age</p></td>
<td align="left">
<p style="text-indent:0em;text-align:left;">Moderna</p></td></tr></tbody></table>
<p style="text-indent:-2em;margin-left:4em;">Local: Injection-site reaction (Moderna: Delayed-onset: 1% to 3%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Hyperhidrosis (Pfizer), night sweats (Pfizer)</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Angioedema (Shimabukuro 2021a)</p>
<p style="text-indent:-2em;margin-left:4em;">Infection: Herpes zoster infection (Moderna)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Local swelling (at or near the site of dermal fillers [eg, face or lips]) (CDC 2022c)</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Asthenia (Pfizer), facial nerve paralysis (including Bell palsy, hypoesthesia, paresthesia; unsolicited, data insufficient to determine causal relationship), lethargy (Pfizer), malaise (Pfizer)</p>
<p style="text-indent:-2em;margin-left:2em;">Frequency not defined: Gastrointestinal: Appendicitis (Pfizer; unsolicited; data insufficient to determine causal relationship)</p>
<p style="text-indent:-2em;margin-left:2em;">Post-authorization/postmarketing:</p>
<p style="text-indent:-2em;margin-left:4em;">Cardiovascular: Myocarditis, pericarditis, syncope (adolescents in particular)</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Bullous pemphigoid (Washrawirul 2022), contact dermatitis (Washrawirul 2022), cutaneous lupus erythematous (Washrawirul 2022), ecchymoses (Washrawirul 2022), eczema (Washrawirul 2022), erythema multiforme (Washrawirul 2022), fixed drug eruption (Washrawirul 2022), lichen planus (Washrawirul 2022), maculopapular rash (Washrawirul 2022), pruritus (Shimabukuro 2021a), psoriasis (Washrawirul 2022), skin rash (Shimabukuro 2021a), Sweet syndrome (Washrawirul 2022), urticaria (Shimabukuro 2021a)</p>
<p style="text-indent:-2em;margin-left:4em;">Endocrine &amp; metabolic: Graves disease (new onset or exacerbation) (Chee 2022)</p>
<p style="text-indent:-2em;margin-left:4em;">Hematologic &amp; oncologic: Immune thrombocytopenia (Washrawirul 2022), petechia (Washrawirul 2022), purpuric disease (Washrawirul 2022)</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Anaphylaxis (Washrawirul 2022), hypersensitivity reaction (Pfizer: Including severe hypersensitivity reactions)</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Dizziness (CDC 2021a)</p>
<p style="text-indent:-2em;margin-left:4em;">Neuromuscular &amp; skeletal: Joint injury (shoulder; unsolicited) (Polack 2020), upper extremity pain (arm) (Pfizer)</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Airway obstruction (Shimabukuro 2021a)</p></div>
<div class="block coi drugH1Div" id="F55186280"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">History of a severe allergic reaction (eg, anaphylaxis) after a previous dose or to a component of the formulation.</p></div>
<div class="block war drugH1Div" id="F55186281"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Concerns related to adverse effects:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Shoulder injury related to vaccine administration: Vaccine administration that is too high on the upper arm may cause shoulder injury (eg, shoulder bursitis, tendinopathy) resulting in shoulder pain and reduced range of motion following injection. Use proper injection technique for vaccines administered in the deltoid muscle (eg, injecting in the central, thickest part of the muscle) to reduce the risk of shoulder injury related to vaccine administration (Cross 2016; Foster 2013).</p>
<p style="text-indent:-2em;margin-left:4em;">• Syncope: Syncope has been reported with use of injectable vaccines and may result in serious secondary injury (eg, skull fracture, cerebral hemorrhage); typically reported in adolescents and young adults and within 15 minutes after vaccination. Procedures should be in place to avoid injuries from falling and to restore cerebral perfusion if syncope occurs (ACIP [Kroger 2023]).</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Disease-related concerns:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Acute illness: The decision to administer or delay vaccination because of current or recent febrile illness depends on the severity of symptoms and the etiology of the disease. In general, it is recommended to defer vaccine administration in patients with moderate or severe acute febrile illness (with or without fever) and to provide vaccination in patients with mild acute illness (with or without fever) (ACIP [Kroger 2023]). Although not included in the Pfizer or Moderna documentation from the FDA, the Canadian product information for the Pfizer vaccine recommends postponing vaccination in patients with acute severe febrile illness. In addition, the Canadian product information for the Moderna vaccine states to consider postponing vaccination in patients with acute severe febrile illness or severe acute infection.</p>
<p style="text-indent:-2em;margin-left:4em;">• Bleeding disorders: Use with caution in patients with bleeding disorders (including thrombocytopenia); bleeding or hematoma may occur from IM administration; if the patient receives antihemophilia or other similar therapy, IM injection can be scheduled shortly after such therapy is administered (ACIP [Kroger 2023]). For more information on administering the COVID-19 vaccine in patients with bleeding disorders, see society recommendations (eg, US National Hemophilia Foundation, World Federation of Hemophilia).</p>
<p style="text-indent:-2em;margin-left:4em;">• Multisystem inflammatory syndrome: In patients with a history of multisystem inflammatory syndrome (MIS), the benefits of vaccination are thought to outweigh the risks in patients who meet 2 recovery criteria: 1) clinical recovery from MIS (including return to baseline cardiac function) and 2) ≥90 days have passed since diagnosis. Vaccination can be considered in patients who do not meet both criteria on a case-by-case basis. In patients who developed MIS within 60 days following a dose of COVID-19 vaccine, decisions about subsequent doses should be made on a case-by-case basis. In patients who developed MIS &gt;60 days after a previous dose of COVID-19 vaccine, subsequent doses should be considered ≥90 days after MIS diagnosis for patients who have clinically recovered (including return to baseline cardiac function) (CDC 2023).</p>
<p style="text-indent:-2em;margin-left:4em;">• Myocarditis/pericarditis (CDC 2023):</p>
<p style="text-indent:-2em;margin-left:6em;">- <i>Persons who experience myocarditis/pericarditis after a dose of the vaccine:</i> For persons who developed myocarditis or pericarditis within 3 weeks after any dose of a COVID-19 vaccine, subsequent doses of any COVID-19 vaccine are generally not recommended. If after risk assessment a decision is made to administer subsequent dose(s), wait until complete resolution of signs/symptoms of myocarditis or pericarditis with no evidence of ongoing heart inflammation or sequelae as determined by clinical team.</p>
<p style="text-indent:-2em;margin-left:6em;">- <i>Persons with history of myocarditis or pericarditis that occurred prior to vaccination or &gt;3 weeks after a COVID-19 vaccine dose:</i> Persons with history of myocarditis or pericarditis that occurred prior to COVID-19 vaccination or &gt;3 weeks after a COVID-19 vaccine dose may receive any FDA-approved or FDA-authorized COVID-19 vaccine after complete resolution of signs/symptoms of myocarditis or pericarditis with no evidence of ongoing heart inflammation or sequelae as determined by clinical team. This also applies to persons who had myocarditis or pericarditis due to SARS-CoV-2 or other viruses.</p>
<p style="text-indent:-2em;margin-left:4em;">• SARS-CoV-2 infection or exposure (CDC 2023):</p>
<p style="text-indent:-2em;margin-left:6em;">- <i>Persons with history of COVID-19 or asymptomatic SARS-CoV-2 infection:</i> Vaccination is recommended for everyone ≥6 months of age (with an age-appropriate COVID-19 vaccine), regardless of history of symptomatic or asymptomatic SARS-CoV-2 infection. Persons who recently had SARS-CoV-2 infection may consider delaying vaccine doses by 3 months from symptom onset or positive test (if asymptomatic); increased time between infection and vaccination may improve vaccination immune response.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>- Persons with current SARS-CoV-2 infection (including asymptomatic): </i>In persons with known current SARS-CoV-2 infection, defer vaccination until the person has recovered from acute illness (if symptomatic) and no longer requires isolation.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>- Persons with known SARS-CoV-2 exposure:</i> Persons with recent known exposure may be vaccinated if they do not have symptoms consistent with COVID-19 infection; follow CDC's postexposure guidance. Vaccination for postexposure prophylaxis is not recommended.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Concurrent drug therapy issues:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Anticoagulant therapy: Clinicians administering vaccine should be aware of potential bleeding or hematoma that could occur due to IM administration (ACIP [Kroger 2023]).</p>
<p style="text-indent:-2em;margin-left:4em;">• Vaccines: The CDC and American Academy of Pediatrics recommend simultaneous administration of the COVID-19 vaccine with other vaccines or administration in the days before and after receipt of other vaccines (AAP 2022; CDC 2023). There is no minimum interval between administration of a COVID-19 vaccine and an orthopoxvirus vaccine (Jynneos or ACAM2000). Because of the risk for myocarditis and pericarditis related to the COVID-19 vaccine and smallpox vaccine (ACAM2000) and the unknown myocarditis and pericarditis risk related to smallpox and monkeypox vaccine (Jynneos or Imvamune), consider waiting 4 weeks between administering an orthopoxvirus vaccine (ACAM2000; Jynneos or Imvamune) and COVID-19 vaccine (especially for adolescent/young adult males). However, vaccination with either agent should not be delayed if the patient is at increased risk for mpox or severe COVID-19. The CDC recommends prioritizing the use of Jynneos over ACAM2000 when coadministering with a COVID-19 vaccine (CDC 2023; CDC/ACIP [Rao 2022]).</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Dosage form specific issues:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Traceability: The vaccine name, batch/lot number, expiration date, and other administration details must be recorded for each patient in order to improve traceability.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Special populations:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Altered immunocompetence: COVID-19 vaccines can be safely administered to immunocompromised persons (including those with HIV or receiving immunosuppressant therapy) if no contraindications exist. Immunocompromised persons may have a diminished immune response to the vaccine, but the potential benefit of the vaccine outweighs the uncertainties. If possible, complete COVID-19 vaccination ≥2 weeks prior to initiation or resumption of immunosuppressive therapy (CDC 2023; NACI 2023). For more information on administering the COVID-19 vaccine in specific disease states, see society recommendations (eg, American Cancer Society, National Multiple Sclerosis Society).</p>
<p style="text-indent:-2em;margin-left:4em;">• Persons who had received dermal fillers: Temporary swelling at or near the site of filler injection has been infrequently reported after COVID-19 (mRNA) vaccination (CDC 2023).</p>
<p style="text-indent:-2em;margin-left:4em;">• Pediatric: Multiple formulations from both manufacturers (Pfizer-BioNTech and Moderna) are available and the ages for which each product is authorized differs. Additionally, the recommended number of doses for some age groups may differ. Use extra caution when selecting formulation, dosage, and preparation prior to administration (ISMP [Smetzer 2022b]).</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Other warnings/precautions:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Effective immunity: Vaccination may not result in effective immunity in all patients. Response depends upon multiple factors (eg, type of vaccine, age of patient) (ACIP [Kroger 2023]).</p>
<p style="text-indent:-2em;margin-left:4em;">• Mammograms: Temporary contralateral or ipsilateral lymphadenopathy after a COVID-19 vaccination has been reported. To avoid possible misinterpretation of mammogram screening, mammograms are recommended prior to vaccination or 4 to 6 weeks after the second dose. When this is not possible, the mammogram technologist or radiologist should be informed when and which vaccine was administered, and what arm the injection was given (ACOG 2023). Imaging needed for acute symptoms, or urgent treatment planning or complications, should not be delayed (Becker 2021).</p></div>
<div class="block foc drugH1Div" id="F55194839"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension, Intramuscular [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Comirnaty: 30 mcg/0.3 mL (0.3 mL) [contains 2-((peg)-2000)-n,n-ditetradecylacetamide]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Moderna COVID-19 Vac 6m-11y: 25 mcg/0.25 mL (0.25 mL) [contains dmg-peg 2000]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Pfizer COVID-19 Vac-TriS 5-11y: 10 mcg/0.3 mL (0.3 mL) [contains 2-((peg)-2000)-n,n-ditetradecylacetamide]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Pfizer COVID-19 Vac-TriS 6m-4y: 3 mcg/0.3 mL (0.9 mL) [contains 2-((peg)-2000)-n,n-ditetradecylacetamide]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Spikevax: 50 mcg/0.5 mL (0.5 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension Prefilled Syringe, Intramuscular: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Comirnaty: 30 mcg/0.3 mL (0.3 mL) [latex free; contains 2-((peg)-2000)-n,n-ditetradecylacetamide]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension Prefilled Syringe, Intramuscular [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Comirnaty: 30 mcg/0.3 mL (0.3 mL) [contains 2-((peg)-2000)-n,n-ditetradecylacetamide]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Spikevax: 50 mcg/0.5 mL (0.5 mL)</p></div>
<div class="block geq drugH1Div" id="F55186275"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block fee drugH1Div" id="F56695230"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension</b> (Comirnaty Intramuscular)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">30 mcg/0.3 ml (per 0.3 mL): $138.00</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension</b> (Moderna COVID-19 Vac 6m-11y Intramuscular)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">25MCG/0.25ML (per 0.25 mL): $153.60</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension</b> (Pfizer COVID-19 Vac-TriS 5-11y Intramuscular)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10 mcg/0.3 ml (per 0.3 mL): $92.40</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension</b> (Spikevax Intramuscular)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">50 mcg/0.5 mL (per 0.5 mL): $153.60</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension Prefilled Syringe</b> (Comirnaty Intramuscular)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">30 mcg/0.3 ml (per 0.3 mL): $144.00</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension Prefilled Syringe</b> (Spikevax Intramuscular)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">50 mcg/0.5 mL (per 0.5 mL): $155.40</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F55194841"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension, Intramuscular: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Comirnaty: 3 mcg/0.2 mL (2.2 mL); 10 mcg/0.2 mL (1 ea) [contains 2-((peg)-2000)-n,n-ditetradecylacetamide]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Comirnaty (Gray Cap): 30 mcg/0.3 mL (1.8 mL) [contains 2-((peg)-2000)-n,n-ditetradecylacetamide]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Comirnaty (Purple Cap): 30 mcg/0.3 mL (1.8 mL) [contains 2-((peg)-2000)-n,n-ditetradecylacetamide]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Comirnaty Omicron XBB.1.5: 3 mcg/0.2 mL (2 mL); 10 mcg/0.3 mL (0.3 mL, 1.8 mL); 30 mcg/0.3 mL (0.3 mL, 1.8 mL, 2 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Comirnaty Original &amp; Omicron: 10 mcg/0.2 mL (1.3 mL); 30 mcg/0.3 mL (0.48 mL, 2.25 mL) [contains 2-((peg)-2000)-n,n-ditetradecylacetamide]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Spikevax: 50 mcg/0.5 mL (2.5 mL); 100 mcg/0.5 mL (5 mL) [contains dmg-peg 2000]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Spikevax Bivalent: 50 mcg/0.5 mL (Original/Omicron BA.1) (2.5 mL) [contains dmg-peg 2000]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Spikevax Orig &amp; Omicron BA.4/5: 50 mcg/0.5 mL (2.5 mL) [contains dmg-peg 2000]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Spikevax XBB.1.5: 0.1 mg/mL (2.5 mL)</p></div>
<div class="block accres drugH1Div" id="F55194831"><span class="drugH1">Prescribing and Access Restrictions</span>
<p style="text-indent:0em;display:inline">The US federal government, in conjunction with state health departments, allocates vaccine supply to individual sites of care across the United States.</p>
<p style="text-indent:0em;margin-top:2em;">As part of the emergency use authorization (EUA), information consistent with fact sheets pertaining to emergency use of the COVID-19 vaccines must be provided to health care providers and recipients/caregivers, and certain mandatory requirements for administration under the EUA must be met as outlined in the FDA EUA letter. Currently, EUAs are used for vaccination in individuals 6 months to &lt;12 years of age. Use in ages ≥12 years has received full approval (no fact sheets are provided).</p>
<p style="text-indent:0em;margin-left:2em;">
<b>Moderna COVID-19 Vaccine:</b></p>
<p style="text-indent:0em;margin-left:4em;">The health care provider fact sheets are located at: <a href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F167208%2Fdownload&amp;token=8RYIFfyLhIBYEqeX7m6uPElZNBlegCzTle2gs0StQlZxS2HOvVk4g52U7SeyaON1ChjQ%2FwThTV4SngG1pKCL2w%3D%3D&amp;TOPIC_ID=130323" target="_blank">https://www.fda.gov/media/167208/download</a>.</p>
<p style="text-indent:0em;margin-left:4em;">The patient fact sheets for recipients and caregivers are located at: <a href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F167209%2Fdownload&amp;token=8RYIFfyLhIBYEqeX7m6uPElZNBlegCzTle2gs0StQlbqiuAcia%2FNhTTkf2yDilnc7d51vE4FTsqVGYnB2G2rHQ%3D%3D&amp;TOPIC_ID=130323" target="_blank">https://www.fda.gov/media/167209/download</a>.</p>
<p style="text-indent:0em;margin-left:2em;">
<b>Pfizer-BioNTech COVID-19 Vaccine:</b></p>
<p style="text-indent:0em;margin-left:4em;">The health care provider fact sheets are located at: <a href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F167211%2Fdownload&amp;token=8RYIFfyLhIBYEqeX7m6uPElZNBlegCzTle2gs0StQlarRNfTPRmK8YYUqSiqMAvI5VvR9YX5pqv02wGxOuKoVQ%3D%3D&amp;TOPIC_ID=130323" target="_blank">https://www.fda.gov/media/167211/download</a>.</p>
<p style="text-indent:0em;margin-left:4em;">The patient fact sheets for recipients and caregivers are located at: <a href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F167212%2Fdownload&amp;token=8RYIFfyLhIBYEqeX7m6uPElZNBlegCzTle2gs0StQla5OMdnwtPLlHD34zTYx1aqRKfG4EaS30bz54TRB8hgzg%3D%3D&amp;TOPIC_ID=130323" target="_blank">https://www.fda.gov/media/167212/download</a>.</p>
<p style="text-indent:0em;margin-top:2em;">The vaccine provider should include vaccination information in the state/local jurisdiction Immunization Information System (IIS) or other designated system and provide a paper record card as a backup.</p>
<p style="text-indent:0em;margin-top:2em;">Additionally, the vaccination provider is responsible for mandatory reporting of the following to the Vaccine Adverse Event Reporting System (VAERS) (<a href="/external-redirect?target_url=https%3A%2F%2Fvaers.hhs.gov%2Freportevent.html&amp;token=8m3rK0tzv73hmwLVujPJP52p3XgjWm4UloYmZ6WEJRVfd5GaRtAZ1R0u1s5w8ORP&amp;TOPIC_ID=130323" target="_blank">https://vaers.hhs.gov/reportevent.html</a> or 1-800-822-7967):</p>
<ul>
<li>
<p style="text-indent:0em;">vaccine administration errors whether or not associated with an adverse event</p></li>
<li>
<p style="text-indent:0em;">serious adverse events (irrespective of attribution to vaccination)</p></li>
<li>
<p style="text-indent:0em;">cases of multisystem inflammatory syndrome (MIS) in adults and children</p></li>
<li>
<p style="text-indent:0em;">cases of myocarditis or pericarditis</p></li>
<li>
<p style="text-indent:0em;">cases of COVID-19 that result in hospitalization or death</p></li></ul>
<p style="text-indent:0em;margin-top:2em;">The vaccination provider is also responsible for responding to FDA requests for more information. Additional adverse events may be reported to VAERS and the manufacturer. Adverse events related to the Pfizer-BioNTech vaccine may be reported to Pfizer via https://www.pfizersafetyreporting.com, 1-800-438-1985, or via fax at 1-866-635-8337. Adverse events related to the Moderna vaccine may be reported to ModernaTx, Inc. via https://report.moderna.convergehealthsafety.com, 1-866-663-3762, or via fax at 1-866-599-1342.</p></div>
<div class="block admp drugH1Div" id="F55187090"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">Parenteral: IM: Administer IM in the deltoid muscle or anterolateral thigh as appropriate for age (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.5']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.5'])">Ref</a></span>). Use proper injection technique in the deltoid muscle (eg, injecting in the central, thickest part of the muscle) to reduce the risk of shoulder injury related to vaccine administration (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27166466','lexi-content-ref-23636163']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27166466','lexi-content-ref-23636163'])">Ref</a></span>). Do not inject intravascularly, SUBQ, or intradermally. To prevent syncope-related injuries, adolescents should be vaccinated while seated or lying down. If administering simultaneously with other vaccines, administer each vaccine at a different injection site (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Kroger.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Kroger.2'])">Ref</a></span>). US recipients or caregivers should be given a vaccination card that includes the name of the vaccine, lot number, the vaccination date, and name of the health care site or person where the vaccine was administered (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-FDA.13','lexi-content-ref-FDA.14']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-FDA.13','lexi-content-ref-FDA.14'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>Moderna vaccine</i>: Prior to use, gently swirl vial; do not shake. Do not pool partial doses remaining in vials into a full dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-FDA.14']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-FDA.14'])">Ref</a></span>). The 2023-2024 formulation single-dose vial for ages 6 months to &lt;12 years (with a green label and dark blue cap) may contain significant overfill; ensure that correct amount (0.25 mL) is withdrawn for patient dose and discard any excess volume (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-FDA.15','lexi-content-ref-ISMP.3']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-FDA.15','lexi-content-ref-ISMP.3'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>Pfizer-BioNTech vaccine</i>: Vials with yellow caps must be diluted prior to use; vials with blue cap and vials and prefilled syringes for patients ≥12 years of age must NOT be diluted. Do not pool partial doses remaining in vials into a full dose.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>Inappropriate administration technique:</i> If administered SUBQ or into a muscle other than the deltoid or anterolateral thigh, do not repeat dose. If additional doses are needed, administer at the recommended interval (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.5']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.5'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>Patients at risk for hemorrhage: </i> For patients at risk of hemorrhage following IM injection, the vaccine should be administered IM if, in the opinion of the physician familiar with the patient's bleeding risk, the vaccine can be administered by this route with reasonable safety. If the patient receives antihemophilia or other similar therapy, IM vaccination can be scheduled shortly after such therapy is administered. A fine needle (23-gauge or smaller) can be used for the vaccination and firm pressure applied to the site (without rubbing) for at least 2 minutes. The patient should be instructed concerning the risk of hematoma from the injection. Patients on anticoagulant therapy should be considered to have the same bleeding risks and treated as those with clotting factor disorders (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Kroger.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Kroger.2'])">Ref</a></span>). For patients with bleeding disorders, specific recommendations are available (eg, US National Hemophilia Foundation, World Federation of Hemophilia).</p></div>
<div class="block adm drugH1Div" id="F55187217"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>IM:</b> Administer IM in the deltoid muscle or anterolateral thigh (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.5']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.5'])">Ref</a></span>). Use proper injection technique in the deltoid muscle (eg, injecting in the central, thickest part of the muscle) to reduce the risk of shoulder injury related to vaccine administration (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27166466','lexi-content-ref-23636163']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27166466','lexi-content-ref-23636163'])">Ref</a></span>). Do not inject intravascularly, SUBQ, or intradermally. To prevent syncope-related injuries, adolescents and adults should be vaccinated while seated or lying down. If administering simultaneously with other vaccines, administer each vaccine at a different injection site (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Kroger.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Kroger.2'])">Ref</a></span>). US recipients or caregivers should be given a vaccination card that includes the name of the vaccine, lot number, the vaccination date, and name of the health care site or person where the vaccine was administered (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-FDA.13','lexi-content-ref-FDA.14']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-FDA.13','lexi-content-ref-FDA.14'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Moderna vaccine</i>: Prior to use, gently swirl vial; do not shake. Do not pool partial doses remaining in vials into a full dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-FDA.14']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-FDA.14'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Pfizer-BioNTech vaccine (vials for ≥12 years of age [no dilution required])</i>: Prior to use, gently invert vial; do not shake. Do not pool partial doses remaining in vials into a full dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-FDA.13']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-FDA.13'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Inappropriate administration technique: </i>If administered SUBQ or into a muscle other than the deltoid or anterolateral thigh (alternate administration site), do <b>not</b> repeat dose. If additional doses are needed, administer at the recommended interval(s) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.5']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.5'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Patients at risk for hemorrhage: </i>For patients at risk of hemorrhage following IM injection, the vaccine should be administered IM if, in the opinion of the physician familiar with the patient's bleeding risk, the vaccine can be administered by this route with reasonable safety. If the patient receives antihemophilia or other similar therapy, IM vaccination can be scheduled shortly after such therapy is administered. A fine needle (23-gauge or smaller) can be used for the vaccination and firm pressure applied to the site (without rubbing) for at least 2 minutes. The patient should be instructed concerning the risk of hematoma from the injection. Patients on anticoagulant therapy should be considered to have the same bleeding risks and treated as those with clotting factor disorders (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Kroger.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Kroger.2'])">Ref</a></span>). For patients with bleeding disorders, specific recommendations are available (eg, US National Hemophilia Foundation, World Federation of Hemophilia).</p></div>
<div class="block sts drugH1Div" id="F55187209"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Temperature excursion and extended storage information may be available; contact manufacturer to obtain current recommendations or for guidance if a dose is administered after improper storage and handling or past the expiration/beyond use date (FDA 2023a; FDA 2023b).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>US products:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Moderna vaccines (FDA 2023b; manufacturer's labeling):</b></p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Note:</b> Minimize exposure to room light during storage; thawed vials can be handled in room light conditions. Avoid exposure to direct sunlight and ultraviolet light.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Storage of frozen vials and prefilled syringes: </i>Store intact vials and prefilled syringes frozen at −50°C to −15°C (−58°F to 5°F).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Thawed vials and prefilled syringes: </i>May store under refrigeration at 2°C to 8°C (36°F to 46°F) for up to 30 days or for a total of 24 hours at room temperature at 8°C to 25°C (46°F to 77°F) prior to use. Thawed vials and prefilled syringes can be handled in room light conditions. Do not refreeze once thawed.</p>
<p style="text-indent:-2em;margin-left:8em;">After first use (puncture): May store for up to 12 hours at 2°C to 25°C (36°F to 77°F).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Transportation of thawed vials:</i> If it is not feasible to transport vials at the recommended freezer temperature, may transport thawed vials for up to 12 hours using shipping containers that will maintain 2°C to 8°C (36°F to 46°F) and under routine road and air transport conditions with shaking and vibration minimized. Once thawed and transported at 2°C to 8°C (36°F to 46°F), vials should not be refrozen; store at 2°C to 8°C (36°F to 46°F) until use (up to 30 days total at 2°C to 8°C [36°F to 46°F]).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Pfizer-BioNTech vaccines (FDA 2023a; manufacturer's labeling):</b></p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Note: </b>Minimize exposure to room light and avoid exposure to direct sunlight and ultraviolet light. Do <b>not </b>refreeze once thawed.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Storage prior to use:</i></p>
<p style="text-indent:-2em;margin-left:8em;">Glass prefilled syringes: Store at 2°C to 8°C (35°F to 46°F); do not freeze. Total time out of the refrigerator at 8°C to 25°C (46°F to 77°F) must not exceed 12 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">Plastic prefilled syringes and vials: For intact prefilled plastic syringes and vials that are received frozen or at 2°C to 8°C (35°F to 46°F), store refrigerated at 2°C to 8°C (35°F to 46°F) for up to 10 weeks. Alternatively, plastic prefilled syringes and vials received frozen may be stored in an ultra-low temperature freezer at −90°C to −60°C (−130°F to −76°F). Do <b>not</b> store at −25°C to −15°C (−13°F to 5°F). Total time out of the refrigerator at 8°C to 25°C (46°F to 77°F) must not exceed 12 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">Regardless of storage condition, do not use after the expiration date printed on the vial and cartons.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Storage during use:</i></p>
<p style="text-indent:-2em;margin-left:8em;">Glass prefilled syringes: If syringe is not used immediately, use within 4 hours of attaching needle.</p>
<p style="text-indent:-2em;margin-left:8em;">Plastic prefilled syringes: Thaw frozen syringes in carton, preferably at 2°C to 8°C (35°F to 46°F) for 2 hours; a full carton may also be thawed at up to 25°C (77°F) for 60 minutes. Once thawed, syringes may be stored in refrigerator for 10 weeks. Individual syringes thawed outside the container at room temperature may be stored at room temperature for up to 4 hours. If syringe is not used immediately, use within 4 hours of attaching needle.</p>
<p style="text-indent:-2em;margin-left:8em;">Vials: If not previously thawed in refrigerator, allow vials to thaw at up to 25°C (77°F) for 30 minutes. Once thawed may be stored at 8°C to 25°C (46°F to 77°F) for up to 12 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">Thawed vials requiring dilution (vials with yellow caps and labels): Thawed vials may be refrigerated at 2°C to 8°C (35°F to 46°F) for up to 10 weeks or stored at room temperature up to 25°C (77°F) for up to 12 hours before dilution. After dilution, store at 2°C to 25°C (35°F to 77°F) for up to 12 hours.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Transportation of frozen vials and prefilled syringes:</i></p>
<p style="text-indent:-2em;margin-left:8em;">Glass prefilled syringes: May be transported at 2°C to 8°C (35°F to 46°F) if local redistribution is needed; do not freeze.</p>
<p style="text-indent:-2em;margin-left:8em;">Plastic prefilled syringes and vials: May be transported at −90°C to −60°C (−130°F to −76°F) or 2°C to 8°C (35°F to 46°F). Plastic prefilled syringes should only be transported at −90°C to −60°C if the cartons are sealed in the original aluminum shipping pouches.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Canadian products:</b></p>
<p style="text-indent:-2em;margin-left:4em;">There are various preparations of COVID-19 vaccines containing different components (eg, SARS-CoV-2 original strain, Omicron BA.1, BA.4/BA.5, and XBB.1.5 variants) approved in Canada. Some products require dilution, and some are ready to use. It is critical to verify product selection; refer to manufacturer’s labeling for detailed preparation and storage instructions.</p></div>
<div class="block meg drugH1Div" id="F58795772"><span class="drugH1">Medication Guide and/or Vaccine Information Statement (VIS)</span>
<p style="text-indent:0em;display:inline">In the United States, the appropriate CDC-approved Vaccine Information Statement (VIS) must be provided to the patient/caregiver before administering each dose of this vaccine; the VIS edition date and date it was provided to the patient/caregiver should be recorded as required by US law; VIS is available at <a href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fhcp%2Fvis%2Fvis-statements%2Fcovid-19.html&amp;token=LHPWWGrSfyA%2BNoLvLtsVf8gbG8BCWDHmumE3B0xrFVEdtsO1OFgcWQcuUAL1%2B67IMTWy7hWnRqfsqGCIyB6UDMkzgcL%2FlIUaYHQHyqeQWjw%3D&amp;TOPIC_ID=130323" target="_blank">https://www.cdc.gov/vaccines/hcp/vis/vis-statements/covid-19.html</a>.</p></div>
<div class="block usep drugH1Div" id="F55186824"><span class="drugH1">Use</span>
<p style="text-indent:-2em;margin-left:2em;">Active immunization to prevent COVID-19.</p>
<p style="text-indent:-2em;margin-left:4em;">2023-2024 Formula (Omicron XBB.1.5): FDA approved in ages ≥12 years and adults; FDA issued emergency use authorization for ages 6 months to &lt;12 years.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> As of September 11, 2023, the only mRNA COVID-19 vaccines now available in the United States are based on the SARS-CoV-2 Omicron variant XBB.1.5 and labeled "2023-2024 Formula".</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<span style="text-decoration: underline">Primary immunization: </span></b></p>
<p style="text-indent:-2em;margin-left:4em;">The CDC recommends that all persons ≥6 months of age receive at least 1 age-appropriate 2023-2024 COVID-19 vaccine. The specific number of doses depends on the person's age, COVID-19 vaccination history, immune status, and vaccine product (CDC 2023).</p>
<p style="text-indent:-2em;margin-left:4em;">Moderate and severe immunocompromising conditions and treatments include but are not limited to (CDC 2023):</p>
<p style="text-indent:-2em;margin-left:6em;">• Active treatment for solid tumor and hematologic malignancies</p>
<p style="text-indent:-2em;margin-left:6em;">• Hematologic malignancies associated with poor responses to COVID-19 vaccines (eg, chronic lymphocytic leukemia, non-Hodgkin lymphoma, multiple myeloma, acute leukemia) regardless of current treatment status</p>
<p style="text-indent:-2em;margin-left:6em;">• Receipt of solid-organ or islet transplant and taking immunosuppressive therapy</p>
<p style="text-indent:-2em;margin-left:6em;">• Receipt of chimeric antigen receptor (CAR)–T-cell or hematopoietic cell transplant (within 2 years of transplantation or taking immunosuppressive therapy)</p>
<p style="text-indent:-2em;margin-left:6em;">• Moderate or severe primary immunodeficiency (eg, common variable immunodeficiency disease, severe combined immunodeficiency, DiGeorge syndrome, Wiskott-Aldrich syndrome)</p>
<p style="text-indent:-2em;margin-left:6em;">• HIV infection (advanced or untreated)</p>
<p style="text-indent:-2em;margin-left:6em;">• Active treatment with any of the following: High-dose corticosteroids (ie, ≥20 mg/day prednisone or equivalent for ≥2 weeks), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor necrosis (TNF) blockers, and other biologic agents that are immunosuppressive or immunomodulatory</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Canadian and international labeling:</i></b>Approved ages vary by product; see product labeling for details.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Preparations of COVID-19 vaccines in Canada and internationally containing different components (eg, SARS-CoV-2 Original strain, Omicron BA.1, BA.4/BA.5, and XBB.1.5 variants) may be available; use caution.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Canadian guidance:</b> The National Advisory Committee on Immunization (NACI) has also made recommendations on the <a href="/external-redirect?target_url=https%3A%2F%2Fwww.canada.ca%2Fen%2Fpublic-health%2Fservices%2Fpublications%2Fhealthy-living%2Fcanadian-immunization-guide-part-4-active-vaccines%2Fpage-26-covid-19-vaccine.html&amp;token=34%2FWP31j4%2Fhv1Go9cm4KqZrb9aRjQ0C2JAPwNJhEyNVOYisux9mPYTwtY86bamD8xGYewujn2MNCYphTsBengTLVhQpvBkO7YHsk%2Be6TTbhRbUxiNA7X0tMF1ciMi%2FoxmFHb0c6mUfzvgtxe3FeAESgjCWPForwBb9BPSc%2FX4GM%3D&amp;TOPIC_ID=130323" target="_blank">use of COVID-19 vaccines; see recommendations for details</a> (NACI 2023; NACI 2023a; NACI 2023b).</p></div>
<div class="block mst drugH1Div" id="F55216367"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Multiple formulations (Pfizer-BioNTech and Moderna) are available; errors related to use of the incorrect formulation have been reported (ISMP [Smetzer 2022a]). Concentrations, dilution requirements, and ingredients vary. Ensure correct formulation, dosage, and preparation prior to administration.</p>
<p style="text-indent:-2em;margin-left:4em;">COVID-19 vaccine may be confused with influenza virus vaccine. Medication errors have occurred when COVID-19 vaccine was inadvertently administered instead of influenza virus vaccine (and vice versa). These products may be stored in close proximity to each other. Confirm the correct vaccine has been selected prior to administration (ISMP/NAN 2021).</p>
<p style="text-indent:-2em;margin-left:4em;">COVID-19 vaccine may be confused with epinephrine injection. Medication errors have occurred when epinephrine injection was inadvertently administered instead of COVID-19 vaccine. Most mix-ups were due to look-alike, predrawn syringes of epinephrine and the vaccine, which were stored in close proximity (ISMP [Smetzer 2022a]).</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Other safety concerns:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Errors related to inaccurate dilution of the Pfizer-BioNTech vaccine formulations have occurred; use caution when diluting the vaccine (Pfizer-BioNTech vaccine with yellow vial cap and label requires dilution; other formulations do not) (FDA 2023a; FDA 2023b; ISMP [Smetzer 2022a]).</p>
<p style="text-indent:-2em;margin-left:4em;">The Moderna 2023-2024 formulation vials (green label and dark blue cap) have significant overfill in the single-use vial. Ensure accurate mL volume before administration to avoid overdose (ISMP 2023).</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F55194871"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F55194868"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Abatacept: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Rheumatology guidelines recommend holding SQ abatacept for 1 to 2 weeks after each vaccine dose and timing vaccine dose so that it is given 1 week prior to the next IV abatacept dose.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Acetaminophen: May diminish the therapeutic effect of Vaccines. Management: Consider avoiding routine prophylactic use of acetaminophen before or during vaccine administration when possible. Acetaminophen is still recommended to treat fevers and/or pain that occurs after vaccination.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Anti-CD20 B-Cell Depleting Therapies: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Administer COVID-19 vaccine 2 to 4 weeks prior to the next scheduled dose of anti-CD20 therapy, if used chronically for the treatment of autoimmune disease. Revaccinate 6 months after completion of anti-CD20 therapy if used over a limited period.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Apremilast: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Rheumatology guidelines recommend holding apremilast for 1 to 2 weeks after vaccine administration as permitted by the underlying disease. These guidelines consider apremilast to be an immunomodulatory or immunosuppressive medication.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">AzaTHIOprine: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Rheumatology guidelines recommend holding azathioprine for 1 to 2 weeks after each vaccine dose as permitted by the underlying disease. This recommendation is specific to patients using azathioprine for rheumatic and musculoskeletal disease.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Baricitinib: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Rheumatology guidelines recommend holding baricitinib, tofactinib, or upadacitinib for 1 to 2 weeks after vaccine administration as permitted by the underlying disease.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Belimumab: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Rheumatology guidelines recommend holding subcutaneous belimumab doses for 1 to 2 weeks after each COVID-19 vaccine dose as disease activity permits. The recommendation specifies subcutaneous belimumab and does not mention intravenous belimumab.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Calcineurin Inhibitors (Systemic): May diminish the therapeutic effect of COVID-19 Vaccines. Management: Rheumatology guidelines recommend holding calcineurin inhibitors for 1 to 2 weeks after each vaccine dose as permitted by the underlying disease. This is specific to the use of calcineurin inhibitors for rheumatologic or musculoskeletal disease.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">CAR-T Cell Immunotherapy: May diminish the therapeutic effect of COVID-19 Vaccine (mRNA). Management: The CDC recommends that CAR-T-cell recipients who received COVID-19 vaccine prior to or during treatment with CAR-T-cell therapy should be revaccinated with a primary vaccine series at least 3 months (12 weeks) after CAR-T-cell therapy.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">CloZAPine: COVID-19 Vaccines may enhance the adverse/toxic effect of CloZAPine. COVID-19 Vaccines may increase the serum concentration of CloZAPine. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Corticosteroids (Systemic): May diminish the therapeutic effect of COVID-19 Vaccine (mRNA). Management: Give a 3-dose primary series for all patients aged 6 months and older taking immunosuppressive medications or therapies. Booster doses are recommended for certain age groups. See CDC guidance for details.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">CycloPHOSphamide: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Adjust timing of intravenous cyclophosphamide so that administration occurs 1 week after each vaccine dose, if feasible; hold oral cyclophosphamide for 1 to 2 weeks after vaccine administration as permitted by the underlying disease.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Dermal Fillers: COVID-19 Vaccine (mRNA) may enhance the adverse/toxic effect of Dermal Fillers. Specifically, the risk for swelling at or near the site of dermal filler injection (usually face or lips) may be increased. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Elivaldogene Autotemcel: May enhance the adverse/toxic effect of Vaccines. Specifically, there may be a greater risk for contracting an infection from any live vaccine. Elivaldogene Autotemcel may diminish the therapeutic effect of Vaccines. Management: Administration of vaccines is not recommended in the 6 weeks before myeloablative conditioning, and until hematologic recovery after elivaldogene autotemcel treatment.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Immunosuppressants (Cytotoxic Chemotherapy): May diminish the therapeutic effect of COVID-19 Vaccine (mRNA). Management: Give a 3-dose primary series for all patients aged 6 months and older taking immunosuppressive medications or therapies. Booster doses are recommended for certain age groups. See CDC guidance for details.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Immunosuppressants (Miscellaneous Oncologic Agents): May diminish the therapeutic effect of COVID-19 Vaccine (mRNA). Management: Give a 3-dose primary series for all patients aged 6 months and older taking immunosuppressive medications or therapies. Booster doses are recommended for certain age groups. See CDC guidance for details.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Immunosuppressants (Therapeutic Immunosuppressant Agents): May diminish the therapeutic effect of COVID-19 Vaccine (mRNA). Management: Give a 3-dose primary series for all patients aged 6 months and older taking immunosuppressive medications or therapies. Booster doses are recommended for certain age groups. See CDC guidance for details.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Leflunomide: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Rheumatology guidelines recommend holding leflunomide for 1 to 2 weeks after vaccine administration as permitted by the underlying disease.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Methotrexate: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Rheumatology guidelines recommend holding methotrexate for 1 to 2 weeks after vaccine administration as permitted by underlying disease. This is specific to patients using methotrexate for rheumatic and musculoskeletal disease.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Mycophenolate: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Rheumatology guidelines recommend holding mycophenolate for 1 to 2 weeks after each vaccine dose as permitted by the underlying disease. This recommendation is specific to patients using mycophenolate for rheumatic and musculoskeletal diseases.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Propacetamol: May diminish the therapeutic effect of Vaccines. Management: Consider avoiding routine prophylactic use of propacetamol before or during vaccine administration when possible. Propacetamol is still recommended to treat fevers and/or pain that occurs after vaccination.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Smallpox and Monkeypox Vaccine (Live): May enhance the adverse/toxic effect of COVID-19 Vaccine (mRNA). Specifically, the risk of myocarditis may be increased.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Smallpox Vaccine Live: May enhance the adverse/toxic effect of COVID-19 Vaccine (mRNA). Specifically, the risk for myocarditis may be increased.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">SulfaSALAzine: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Rheumatology guidelines recommend holding sulfasalazine for 1 to 2 weeks after vaccine administration as permitted by the underlying disease. These guidelines consider sulfasalazine to be an immunomodulatory or immunosuppressive medication.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Teplizumab: May diminish the therapeutic effect of COVID-19 Vaccine (mRNA). Management: mRNA vaccines are not recommended during the 2 weeks before teplizumab, during treatment, or for 6 weeks afterward. The CDC recommends a 3-dose primary series for all patients aged 6 months and older taking immunosuppressive medications or therapies.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Tixagevimab and Cilgavimab: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Wait at least 2 weeks after receipt of a COVID-19 vaccine before administering tixagevimab and cilgavimab for pre-exposure prophylaxis.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Tofacitinib: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Rheumatology guidelines recommend holding baricitinib, tofactinib, or upadacitinib for 1 to 2 weeks after vaccine administration as permitted by the underlying disease.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Upadacitinib: May diminish the therapeutic effect of COVID-19 Vaccines. Management: Rheumatology guidelines recommend holding baricitinib, tofactinib, or upadacitinib for 1 to 2 weeks after vaccine administration as permitted by the underlying disease.<i> Risk D: Consider therapy modification</i></p></div>
<div class="block rep_considerations drugH1Div" id="F55198188"><span class="drugH1">Reproductive Considerations</span>
<p style="text-indent:0em;">Pregnancy testing is not required prior to vaccination. Pregnancy does not need to be delayed following vaccination. mRNA COVID-19 vaccines are not a cause of infertility (ACOG 2023).</p>
<p style="text-indent:0em;margin-top:2em;">There have been anecdotal reports of temporary menstrual changes following vaccination. Vaccines have not previously been associated with menstrual disturbances; however, environmental stresses can temporarily impact menses. Based on available data, any changes in the length of menstrual cycle following COVID-19 vaccination are &lt;1 day, and changes in duration or quantity of bleeding resolve within 1 to 2 menstrual cycles. COVID-19 vaccines may be given to patients who are menstruating, and vaccination does not need to be scheduled based on menstrual cycle. Potential changes in menstrual bleeding are not a reason to avoid vaccination (ACOG 2023).</p>
<p style="text-indent:0em;margin-top:2em;">Due to the risk of severe illness, pregnancy complications, and death from COVID-19 infection during pregnancy, staying current with COVID-19 vaccination is strongly recommended for all patients planning a pregnancy, patients trying to become pregnant now, and patients who might become pregnant in the future, including those patients previously diagnosed with COVID-19 infection (ACOG 2023; CDC 2023). Refer to current CDC guidelines for vaccination of adults.</p></div>
<div class="block pri drugH1Div" id="F55195448"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Antibodies generated following vaccination of pregnant patients can be detected in cord blood. Placental transfer of IgG antibodies to the neonate increases from time of vaccination to delivery following administration of an mRNA COVID-19 vaccine during pregnancy (Fu 2022; Rawal 2022). Antibodies generated in response to the vaccine persist in the infant serum for up to 6 months of age and are higher than those in infants born to infected mothers (Rawal 2022; Shook 2022). Administration of the mRNA vaccine during pregnancy decreases hospitalization due to COVID-19 infection in infants &lt;6 months of age (Halasa 2022a; Halasa 2022b).</p>
<p style="text-indent:0em;margin-top:2em;">There was no increased risk of congenital fetal anomalies (identified via ultrasonography) based on data collected from 1,149 pregnant patients vaccinated within 30 days prior to conception until 14 weeks' gestation when compared to nonvaccinated pregnant patients (n=534) or pregnant patients vaccinated outside of this time period (n=1,473) (ACOG 2023; Ruderman 2022). Meta-analyses, one which included data from the V-safe Surveillance System and pregnancy registry and the Vaccine Adverse Event Reporting System (VAERS), found the rates of small for gestational age, stillbirth, preterm birth, miscarriage, and congenital anomalies to be similar following COVID-19 vaccination when compared to the general population (Ma 2022; Rawal 2022). The rates of gestational diabetes, gestational hypertension, preeclampsia, or eclampsia following COVID-19 vaccination are also within the known background rate (ACOG 2023; Ma 2022; Rawal 2022). In addition, no safety concerns were detected in a meta-analysis of studies following maternal vaccination with an mRNA COVID-19 vaccine (ACOG 2023; Ciapponi 2023).</p>
<p style="text-indent:0em;margin-top:2em;">The immune response generated by the COVID-19 (mRNA) vaccine in pregnant patients is comparable to the immune response in patients who are not pregnant (ACOG 2023). Meta-analyses of available studies have found the antibody response in pregnant patients provided by vaccination to be higher than that following natural infection (Fu 2022; Rawal 2022). The rates of injection-site pain, injection-site soreness, and fatigue occurred at rates similar to nonpregnant patients (Fu 2022; Rawal 2022). Using data from the VAERS, reports of acute adverse events requiring medical attention following vaccination during pregnancy are uncommon (DeSilva 2022). A large observational cohort study evaluating the COVID-19 (mRNA) vaccine found the incidence of significant adverse health events to be lower in vaccinated pregnant patients compared to age-matched unvaccinated pregnant persons (Sadarangani 2022). COVID-19 vaccination effectively prevents COVID-19 infection and hospitalization in pregnant patients (Ma 2022; Rawal 2022). If severe infection and hospitalization occur, pregnant patients who are vaccinated are significantly less likely to require ICU admission, intubation, or die (de Freitas Paganoti 2022). Based on available data, mRNA vaccines are likely to have the same safety and efficacy in pregnant and nonpregnant patients (ACOG 2023).</p>
<p style="text-indent:0em;margin-top:2em;">The risk of severe illness from COVID-19 infection is increased in symptomatic pregnant patients compared to nonpregnant patients. Pregnant and recently pregnant patients with moderate or severe infection are at increased risk of complications such as hypertensive disorders of pregnancy, postpartum hemorrhage, or other infections compared to pregnant patients without COVID-19. Pregnant patients with symptoms may require ICU admission, mechanical ventilation, or ventilatory support (ECMO) compared to symptomatic nonpregnant patients. Other adverse pregnancy outcomes include preterm birth and stillbirth. The risk of coagulopathy, cesarean delivery, and maternal death may be increased; neonates have an increased risk for NICU admission. Maternal age and comorbidities such as diabetes, hypertension, lung disease, and obesity may also increase the risk of severe illness in pregnant and recently pregnant patients (ACOG FAQ 2023; NIH 2023).</p>
<p style="text-indent:0em;margin-top:2em;">Due to the risk of severe illness, pregnancy complications, and death from COVID-19 infection during pregnancy, staying current with COVID-19 vaccination is strongly recommended for pregnant patients (ACOG 2023; CDC 2023). Refer to current CDC guidelines for vaccination of adults.</p>
<p style="text-indent:0em;margin-top:2em;">Vaccination of pregnant patients may be done in any setting authorized to administer the vaccine. The COVID-19 vaccine may be administered in any trimester and should be given as soon as possible to maximize maternal and fetal health. COVID-19 vaccines may be administered simultaneously with other vaccines routinely administered during pregnancy. Vaccination status should be documented for all pregnant patients; for patients who do not receive the COVID-19 vaccine, the discussion should be documented in the medical record and vaccination offered again at subsequent visits (ACOG 2023).</p>
<p style="text-indent:0em;margin-top:2em;">Rho(D) immune globulin is not expected to interfere with an immune response to the COVID-19 vaccine. Treatment should not be withheld in patients planning to be vaccinated or who recently received the COVID-19 vaccine (ACOG 2023).</p>
<p style="text-indent:0em;margin-top:2em;">Information related to COVID-19 vaccines continues to emerge; refer to current guidelines for vaccinating pregnant patients.</p>
<p style="text-indent:0em;margin-top:2em;">Data collection to monitor maternal and infant outcomes following exposure to COVID-19 vaccines during pregnancy is ongoing:</p>
<p style="text-indent:-2em;margin-left:4em;">- Health care providers are encouraged to enroll patients exposed to the Moderna COVID-19 Vaccine during pregnancy in the Moderna Pregnancy Registry (1-866-663-3762).</p>
<p style="text-indent:-2em;margin-left:4em;">- Health care providers are encouraged to enroll patients exposed to COVID-19 mRNA vaccines during the last 2 months of pregnancy in the Organization of Teratology Information Specialists (OTIS) pregnancy registry (1-877-311-8972; https://mothertobaby.org/join-study/).</p></div>
<div class="block mopp drugH1Div" id="F55187202"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Observe for hypersensitivity and syncope for 15 minutes following administration (ACIP [Kroger 2023]; CDC 2023). Observe patients for 30 minutes after vaccination in those with the following: a history of nonsevere, immediate (within 4 hours) allergic reaction after receipt of a COVID-19 vaccine; a history of anaphylaxis following receipt of a non–COVID-19 vaccine or injectable therapy, or an allergy-related contraindication to a different type of COVID-19 vaccine (CDC 2023). If seizure-like activity associated with syncope occurs, maintain patient in supine or Trendelenburg position to reestablish adequate cerebral perfusion.</p>
<p style="text-indent:0em;margin-top:2em;">Antibody testing to assess for SARS-CoV-2 immunity before or following vaccination is not currently recommended (CDC 2023).</p></div>
<div class="block pha drugH1Div" id="F55187211"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Promotes active immunization against COVID-19 caused by SARS-CoV-2 virus. The modified messenger RNA (mRNA) in the vaccine is formulated in lipid particles that enable delivery of the RNA into host cells to allow expression of the SARS-CoV-2 spike (S) antigen. The vaccine elicits both neutralizing antibody and cellular immune responses to the S antigen, which protects against COVID-19 disease.</p></div>
<div class="block phk drugH1Div" id="F55346953"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Onset of action:</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Moderna vaccine:</i> Vaccine efficacy assessment was based on disease cases occurring 14 days or more after dose 2 (Baden 2020). Virus-neutralizing antibody activity was detected in all patients by day 15 following the second dose (Jackson 2020).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Pfizer-BioNTech vaccine: </i>Vaccine efficacy assessment was based on disease cases occurring 7 days or more after dose 2 (Polack 2020). Virus-neutralizing antibody activity peaked 7 to 14 days following the second dose (Walsh 2020).</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58216407"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">COVID-19 vaccine Moderna | Pfizer BioNTech COVID-19 vaccine</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | Spikevax</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(BO)</span> <span class="country">Bolivia, Plurinational State of</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Spikevax</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">COVID-19 vaccine Moderna | Pfizer BioNTech COVID-19 vaccine | Spikevax</span>;</li>
<li>
<span class="countryCode">(CY)</span> <span class="country">Cyprus</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(DK)</span> <span class="country">Denmark</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">Pfizer BioNTech COVID-19 vaccine</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(HR)</span> <span class="country">Croatia</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | Moderna COVID-19 vaccine</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | Moderna COVID-19 vaccine | Pfizer BioNTech COVID-19 vaccine</span>;</li>
<li>
<span class="countryCode">(IS)</span> <span class="country">Iceland</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | Spikevax</span>;</li>
<li>
<span class="countryCode">(LI)</span> <span class="country">Liechtenstein</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(MT)</span> <span class="country">Malta</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | Spikevax</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">Moderna COVID-19 vaccine | Pfizer BioNTech COVID-19 vaccine</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty</span>;</li>
<li>
<span class="countryCode">(PA)</span> <span class="country">Panama</span><span class="countrySeparator">: </span><span class="drugName">Vacuna Pfizer-BioNTech COVID-19</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">COVID-19 vaccine Moderna | Pfizer BioNTech COVID-19 vaccine</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Moderna COVID-19 vaccine | Pfizer BioNTech COVID-19 vaccine</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Pfizer BioNTech COVID-19 vaccine</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | Moderna COVID-19 vaccine | Pfizer BioNTech COVID-19 vaccine</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty | COVID-19 vaccine Moderna | Spikevax</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">COVID-19 vaccine Moderna | Pfizer BioNTech COVID-19 vaccine</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Spikevax</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Comirnaty</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-35080199">
<a name="35080199"></a>Aharon D, Lederman M, Ghofranian A, et al. In vitro fertilization and early pregnancy outcomes after coronavirus disease 2019 (COVID-19) vaccination. <i>Obstet Gynecol</i>. Published online January 25, 2022. doi:10.1097/AOG.0000000000004713<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35080199/pubmed" id="35080199" target="_blank">35080199</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35716376">
<a name="35716376"></a>American Academy of Pediatrics (AAP) Committee on Infectious Diseases. COVID-19 vaccines in infants, children, and adolescents. <i>Pediatrics</i>. Published online June 18, 2022. doi:10.1542/peds.2022-058700. https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2022-058700/188297/COVID-19-Vaccines-in-Infants-Children-and
                     <span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35716376/pubmed" id="35716376" target="_blank">35716376</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ACOG.1">
<a name="ACOG.1"></a>American College of Obstetricians and Gynecologists (ACOG). COVID-19 vaccination considerations for obstetric–gynecologic care. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-pregnant-and-lactating-patients-against-covid-19. Updated September 25, 2023. Accessed September 26, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ACOG.2">
<a name="ACOG.2"></a>American College of Obstetricians and Gynecologists (ACOG). COVID-19 FAQs for obstetricians-gynecologists, obstetrics. https://www.acog.org/clinical-information/physician-faqs/covid-19-faqs-for-ob-gyns-obstetrics. Accessed September 21, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33378609">
<a name="33378609"></a>Baden LR, El Sahly HM, Essink B, et al; COVE Study Group. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. <i>N Engl J Med</i>. Published online December 30, 2020. doi:10.1056/NEJMoa2035389<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/33378609/pubmed" id="33378609" target="_blank">33378609</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33625298">
<a name="33625298"></a>Becker AS, Perez-Johnston R, Chikarmane SA, et al. Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: <i>Radiology</i> Scientific Expert Panel. <i>Radiology</i>. Published online February 24, 2021. doi:10.1148/radiol.2021210436<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/33625298/pubmed" id="33625298" target="_blank">33625298</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33657292">
<a name="33657292"></a>Blumenthal KG, Freeman EE, Saff RR, et al. Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2 [published online ahead of print, 2021 Mar 3]. <i>N Engl J Med</i>. 2021;10.1056/NEJMc2102131. doi:10.1056/NEJMc2102131<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/33657292/pubmed" id="33657292" target="_blank">33657292</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NACI.1">
<a name="NACI.1"></a>Canadian National Advisory Committee on Immunization (NACI). COVID-19 vaccines: Canadian Immunization Guide. <a href="https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-26-covid-19-vaccine.html" target="_blank">https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-26-covid-19-vaccine.html</a>. Updated June 27, 2023. Accessed September 19, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NACI.3">
<a name="NACI.3"></a>Canadian National Advisory Committee on Immunization (NACI). Addendum to the guidance on the use of COVID-19 vaccines in the fall of 2023. <a href="https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-addendum-guidance-use-covid-19-vaccines-fall-2023.html" target="_blank">https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-addendum-guidance-use-covid-19-vaccines-fall-2023.html</a>. Updated September 12, 2023a. Accessed September 19, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NACI.4">
<a name="NACI.4"></a>Canadian National Advisory Committee on Immunization (NACI). Guidance on the use of COVID-19 vaccines in the fall of 2023. <a href="https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-guidance-use-covid-19-vaccines-fall-2023.html" target="_blank">https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-guidance-use-covid-19-vaccines-fall-2023.html</a>. Updated July 11, 2023b. Accessed September 19, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NACI.2">
<a name="NACI.2"></a>Canadian National Advisory Committee on Immunization (NACI). Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines. <a href="https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-bivalent-Omicron-containing-mrna-covid-19-vaccines.pdf" target="_blank">https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-bivalent-Omicron-containing-mrna-covid-19-vaccines.pdf</a>. Updated September 1, 2022. Accessed September 8, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.1">
<a name="CDC.1"></a>Centers for Disease Control and Prevention (CDC) COVID-19 Response Team; Food and Drug Administration (FDA): First month of COVID-19 vaccine safety monitoring – United States, December 14, 2020-January 13, 2021. <i>MMWR Morb Mortal Wkly Rep. </i>2021a;70(8): 283-288. doi:10.15585/mmwr.mm7008e3</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.4">
<a name="CDC.4"></a>Centers for Disease Control and Prevention (CDC). Clinical considerations: myocarditis and pericarditis after receipt of mRNA COVID-19 vaccines among adolescents and young adults. <a href="https://www.cdc.gov/vaccines/covid-19/clinical-considerations/myocarditis.html" target="_blank">https://www.cdc.gov/vaccines/covid-19/clinical-considerations/myocarditis.html</a>. Updated May 28, 2021b. Accessed June 30, 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.5">
<a name="CDC.5"></a>Centers for Disease Control and Prevention (CDC). Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. <a href="https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html" target="_blank">https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html</a>. Updated October 24, 2023. Accessed October 31, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.2">
<a name="CDC.2"></a>Centers for Disease Control and Prevention (CDC). Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. <a href="https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html" target="_blank">https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html</a>. Updated December 8, 2022c. Accessed December 12, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35235663">
<a name="35235663"></a>Chee YJ, Liew H, Hoi WH, et al. SARS-CoV-2 mRNA vaccination and Graves' disease: a report of 12 cases and review of the literature. <i>J Clin Endocrinol Metab</i>. Published online March 2, 2022. doi:10.1210/clinem/dgac119<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35235663/pubmed" id="35235663" target="_blank">35235663</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-37012114">
<a name="37012114"></a>Ciapponi A, Berrueta M, P K Parker E, et al. Safety of COVID-19 vaccines during pregnancy: a systematic review and meta-analysis. <i>Vaccine</i>. Published online March 27, 2023. doi:10.1016/j.vaccine.2023.03.038<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/37012114/pubmed" id="37012114" target="_blank">37012114</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Comirnaty.1">
<a name="Comirnaty.1"></a>Comirnaty (COVID-19 Vaccine [mRNA]) [prescribing information]. New York, NY: Pfizer; October 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Moderna.1">
<a name="Moderna.1"></a>Comirnaty (COVID-19 Vaccine [mRNA]) [product monograph]. Kirkland, Quebec, Canada: Pfizer Canada ULC; March 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Pfizer.1">
<a name="Pfizer.1"></a>Comirnaty Omicron XBB.1.5 (COVID-19 Vaccine [mRNA], Monovalent [Omicron XBB.1.5]) [product monograph]. Kirkland, Quebec, Canada: Pfizer Canada ULC; September 2023.</div>
</li>
<li>
<div class="reference">
                  Comirnaty Original and Omicron BA.4/BA.5 (COVID-19 Vaccine [mRNA], Bivalent [original and Omicron BA.4/BA.5]) [product monograph]. Kirkland, Quebec, Canada: Pfizer Canada ULC; September 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27166466">
<a name="27166466"></a>Cross GB, Moghaddas J, Buttery J, Ayoub S, Korman TM. Don't aim too high: avoiding shoulder injury related to vaccine administration. <i>Aust Fam Physician</i>. 2016;45(5):303-306.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/27166466/pubmed" id="27166466" target="_blank">27166466</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35632505">
<a name="35632505"></a>de Freitas Paganoti C, Alkmin da Costa R, Papageorghiou AT, et al. COVID-19 vaccines confer protection in hospitalized pregnant and postpartum women with severe COVID-19: a retrospective cohort study. <i>Vaccines (Basel)</i>. 2022;10(5):749. doi:10.3390/vaccines10050749<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35632505/pubmed" id="35632505" target="_blank">35632505</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35731916">
<a name="35731916"></a>DeSilva M, Haapala J, Vazquez-Benitez G, et al. Evaluation of acute adverse events after Covid-19 vaccination during pregnancy. <i>N Engl J Med</i>. 2022;387(2):187-189. doi:10.1056/NEJMc2205276<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35731916/pubmed" id="35731916" target="_blank">35731916</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35398583">
<a name="35398583"></a>Dick A, Rosenbloom JI, Karavani G, Gutman-Ido E, Lessans N, Chill HH. Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy. <i>Am J Obstet Gynecol MFM</i>. 2022;4(4):100637. doi:10.1016/j.ajogmf.2022.100637<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35398583/pubmed" id="35398583" target="_blank">35398583</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-36723944">
<a name="36723944"></a>Duperrex O, Tommasini F, Muller YD. Incidence of chronic spontaneous urticaria following receipt of the COVID-19 vaccine booster in Switzerland. <i>JAMA Netw Open</i>. 2023;6(2):e2254298. doi:10.1001/jamanetworkopen.2022.54298<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/36723944/pubmed" id="36723944" target="_blank">36723944</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23636163">
<a name="23636163"></a>Foster SL, Davis MV. Vaccine administration: preventing serious shoulder injuries. <i>J Am Pharm Assoc (2003)</i>. 2013;53(1):102-103. doi:10.1331/JAPhA.2013.13503<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/23636163/pubmed" id="23636163" target="_blank">23636163</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34735722">
<a name="34735722"></a>Fu W, Sivajohan B, McClymont E, et al. Systematic review of the safety, immunogenicity, and effectiveness of COVID-19 vaccines in pregnant and lactating individuals and their infants. <i>Int J Gynaecol Obstet</i>. 2022;156(3):406-417. doi:10.1002/ijgo.14008<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/34735722/pubmed" id="34735722" target="_blank">34735722</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34804068">
<a name="34804068"></a>Golan Y, Prahl M, Cassidy AG, et al. COVID-19 mRNA vaccination in lactation: assessment of adverse events and vaccine related antibodies in mother-infant dyads. <i>Front Immunol</i>. 2021;12:777103. doi:10.3389/fimmu.2021.777103<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/34804068/pubmed" id="34804068" target="_blank">34804068</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34153517">
<a name="34153517"></a>Greenhawt M, Abrams EM, Shaker M, et al. The risk of allergic reaction to SARS-CoV-2 Vaccines and recommended evaluation and management: a systematic review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. <i>J Allergy Clin Immunol Pract</i>. 2021;9(10):3546-3567. doi:10.1016/j.jaip.2021.06.006<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/34153517/pubmed" id="34153517" target="_blank">34153517</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35731908">
<a name="35731908"></a>Halasa NB, Olson SM, Staat MA, et al; Overcoming Covid-19 Investigators. Maternal vaccination and risk of hospitalization for Covid-19 among infants. <i>N Engl J Med</i>. 2022b;387(2):109-119. doi:10.1056/NEJMoa2204399<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35731908/pubmed" id="35731908" target="_blank">35731908</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35176002">
<a name="35176002"></a>Halasa NB, Olson SM, Staat MA, et al; Overcoming COVID-19 Investigators; Overcoming COVID-19 Network. Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19-associated hospitalization in infants aged &lt;6 months - 17 states, July 2021-January 2022. <i>MMWR Morb Mortal Wkly Rep</i>. 2022a;71(7):264-270. doi:10.15585/mmwr.mm7107e3<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35176002/pubmed" id="35176002" target="_blank">35176002</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-36156636">
<a name="36156636"></a>Hanna N, Heffes-Doon A, Lin X, et al. Detection of messenger RNA COVID-19 vaccines in human breast milk. <i>JAMA Pediatr</i>. 2022;176(12):1268-1270. doi:10.1001/jamapediatrics.2022.3581<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/36156636/pubmed" id="36156636" target="_blank">36156636</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Canada.1">
<a name="Canada.1"></a>Health Canada. Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. <a href="https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/interim-order-import-sale-advertising-drugs.html#a2.8" target="_blank">https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/interim-order-import-sale-advertising-drugs.html#a2.8</a>. Updated September 16, 2020a. Accessed December 10, 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ISMP.1">
<a name="ISMP.1"></a>Institute for Safe Medication Practices (ISMP). COVID-19 vaccine package concerns. <i>ISMP Medication Safety Alert</i>. https://www.ismp.org/acute-care/medication-safety-alert-july-14-2022 Published July 14, 2022. Accessed August 16, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ISMP.3">
<a name="ISMP.3"></a>Institute for Safe Medication Practices (ISMP). Moderna COVID-19 vaccine overfill leads to a double dose. <i>ISMP Medication Safety Alert</i>. https://www.ismp.org/communityambulatory/medication-safety-alert-october-2023. Published October 2023. Accessed November 1, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ISMP.2">
<a name="ISMP.2"></a>Institute for Safe Medication Practices (ISMP); The National Alert Network (NAN). Mix-ups between the influenza (flu) vaccine and COVID-19 vaccine. https://www.ismp.org/alerts/mix-ups-between-influenza-flu-vaccine-and-covid-19-vaccines. Published October 15, 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32663912">
<a name="32663912"></a>Jackson LA, Anderson EJ, Rouphael NG, et al; mRNA-1273 Study Group. An mRNA vaccine against SARS-CoV-2 - preliminary report. <i>N Engl J Med</i>. 2020;383(20):1920-1931. doi:10.1056/NEJMoa2022483<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/32663912/pubmed" id="32663912" target="_blank">32663912</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33978670">
<a name="33978670"></a>Johnston MS, Galan A, Watsky KL, Little AJ. Delayed localized hypersensitivity reactions to the Moderna COVID-19 vaccine: a case series. <i>JAMA Dermatol</i>. Published online May 12, 2021. doi:10.1001/jamadermatol.2021.1214<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/33978670/pubmed" id="33978670" target="_blank">33978670</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34564695">
<a name="34564695"></a>Kashani-Ligumsky L, Lopian M, Cohen R, et al. Titers of SARS CoV-2 antibodies in cord blood of neonates whose mothers contracted SARS CoV-2 (COVID-19) during pregnancy and in those whose mothers were vaccinated with mRNA to SARS CoV-2 during pregnancy. <i>J Perinatol</i>. 2021;41(11):2621-2624. doi:10.1038/s41372-021-01216-1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/34564695/pubmed" id="34564695" target="_blank">34564695</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34678498">
<a name="34678498"></a>Koo G, Anvari S, Friedman DL, et al. mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to pegaspargase. <i>J Allergy Clin Immunol Pract</i>. 2022;10(1):322-325. doi:10.1016/j.jaip.2021.09.051<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/34678498/pubmed" id="34678498" target="_blank">34678498</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Kroger.1">
<a name="Kroger.1"></a>Kroger A, Bahta L, Hunter P. General best practice guidelines for immunization: best practices guidance of the Advisory Committee on Immunization Practices (ACIP). <a href="https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/downloads/general-recs.pdf" target="_blank">https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/downloads/general-recs.pdf</a>. Accessed October 10, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Kroger.2">
<a name="Kroger.2"></a>Kroger A, Bahta L, Long S, Sanchez P. General best practice guidelines for immunization: best practices guidance of the Advisory Committee on Immunization Practices (ACIP). <a href="https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/downloads/general-recs.pdf" target="_blank">https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/downloads/general-recs.pdf</a>. Updated February 10, 2023. Accessed May 10, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35426744">
<a name="35426744"></a>Lamers M, van der Mijle A, van Hunsel F, de Vries L, van Puijenbroek E, Ceulemans M. <i>Letter to the editor:</i> COVID-19 vaccination during breastfeeding and its possible negative effect on milk production and supply: a preliminary observation. <i>Breastfeed Med</i>. 2022. doi:10.1089/bfm.2022.0057<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35426744/pubmed" id="35426744" target="_blank">35426744</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34413319">
<a name="34413319"></a>Low JM, Gu Y, Ng MSF, et al. Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees. <i>NPJ Vaccines.</i> 2021;6(1):105. doi:10.1038/s41541-021-00370-z<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/34413319/pubmed" id="34413319" target="_blank">34413319</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35214704">
<a name="35214704"></a>Ma Y, Deng J, Liu Q, Du M, Liu M, Liu J. Effectiveness and safety of COVID-19 vaccine among pregnant women in real-world studies: a systematic review and meta-analysis. <i>Vaccines (Basel)</i>. 2022;10(2):246. doi:10.3390/vaccines10020246<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35214704/pubmed" id="35214704" target="_blank">35214704</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34670062">
<a name="34670062"></a>Magnus MC, Gjessing HK, Eide HN, Wilcox AJ, Fell DB, Håberg SE. Covid-19 vaccination during pregnancy and first-trimester miscarriage. <i>N Engl J Med</i>. 2021. doi:10.1056/NEJMc2114466<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/34670062/pubmed" id="34670062" target="_blank">34670062</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34398511">
<a name="34398511"></a>Mark C, Gupta S, Punnett A, et al. Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase. <i>Pediatr Blood Cancer</i>. 2021;68(11):e29295. doi:10.1002/pbc.29295<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/34398511/pubmed" id="34398511" target="_blank">34398511</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Moderna.3">
<a name="Moderna.3"></a>Moderna manufacturer communication September 14, 2022. Data on file.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35926203">
<a name="35926203"></a>Moro PL, Olson CK, Zhang B, Marquez P, Strid P. Safety of booster doses of Coronavirus disease 2019 (COVID-19) vaccine in pregnancy in the vaccine adverse event reporting system. <i>Obstet Gynecol.</i> 2022;140(3):421-427. doi:10.1097/AOG.0000000000004889<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35926203/pubmed" id="35926203" target="_blank">35926203</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35464406">
<a name="35464406"></a>Muyldermans J, De Weerdt L, De Brabandere L, Maertens K, Tommelein E. The effects of COVID-19 vaccination on lactating women: a systematic review of the literature. <i>Front Immunol</i>. 2022;13:852928. doi:10.3389/fimmu.2022.852928<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35464406/pubmed" id="35464406" target="_blank">35464406</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NIH.1">
<a name="NIH.1"></a>National Institutes of Health. COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. <a href="https://www.covid19treatmentguidelines.nih.gov/" target="_blank">https://www.covid19treatmentguidelines.nih.gov/</a>. Updated April 20, 2023. Accessed April 25, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33332292">
<a name="33332292"></a>Oliver S, Gargano J, Marin M, et al. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020. <i>MMWR Morb Mortal Wkly Rep</i>. 2020;69(50):1922-1924. doi:10.15585/mmwr.mm6950e2<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/33332292/pubmed" id="33332292" target="_blank">33332292</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33382675">
<a name="33382675"></a>Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices' interim recommendation for use of Moderna COVID-19 Vaccine - United States, December 2020. <i>MMWR Morb Mortal Wkly Rep</i>. 2021a;69(5152):1653-1656. doi: 10.15585/mmwr.mm695152e1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/33382675/pubmed" id="33382675" target="_blank">33382675</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33661860">
<a name="33661860"></a>Oliver SE, Gargano JW, Scobie H, et al. The Advisory Committee on Immunization Practices' interim recommendation for use of Janssen COVID-19 vaccine - United States, February 2021. <i>MMWR Morb Mortal Wkly Rep</i>. 2021b;70(9):329-332. doi:10.15585/mmwr.mm7009e4<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/33661860/pubmed" id="33661860" target="_blank">33661860</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33985514">
<a name="33985514"></a>Orvieto R, Noach-Hirsh M, Segev-Zahav A, Haas J, Nahum R, Aizer A. Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle? <i>Reprod Biol Endocrinol</i>. 2021;19(1):69. doi:10.1186/s12958-021-00757-6<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/33985514/pubmed" id="33985514" target="_blank">33985514</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35288274">
<a name="35288274"></a>Otani IM, Tsao LR, Tang M. Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics. <i>Ann Allergy Asthma Immunol</i>. 2022;129(1):88-94.e1. doi:10.1016/j.anai.2022.03.006<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35288274/pubmed" id="35288274" target="_blank">35288274</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34949564">
<a name="34949564"></a>Picard M, Drolet JP, Masse MS, et al. Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: a case series. <i>J Allergy Clin Immunol Pract</i>. 2022;10(2):620-625.e1. doi:10.1016/j.jaip.2021.11.021<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/34949564/pubmed" id="34949564" target="_blank">34949564</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Pfizer.3">
<a name="Pfizer.3"></a>Pfizer. Pfizer-BioNTech COVID-19 Vaccine - overfill volume in multi-dose vial. https://www.pfizermedicalinformation.com/en-us/document/a0r5I000001MzbtQAC. Published December 17, 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Pfizer.4">
<a name="Pfizer.4"></a>Pfizer manufacturer communication. Storage and Handling of Diluted Vials Outside of Recommendations in the EUA Prescribing Information During and After Dilution. January 21, 2021. Data on file.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Pfizer.5">
<a name="Pfizer.5"></a>Pfizer manufacturer communication. Storage of vaccine in SYRINGE-information outside the EUA PI (for 12 years of age and older-GRAYCAP). January 14, 2022. Data on file.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35830976">
<a name="35830976"></a>Pillay J, Gaudet L, Wingert A, et al. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review. <i>BMJ</i>. 2022;378:e069445. doi:10.1136/bmj-2021-069445<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35830976/pubmed" id="35830976" target="_blank">35830976</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33301246">
<a name="33301246"></a>Polack FP, Thomas SJ, Kitchin N, et al; C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. <i>N Engl J Med</i>. Published online December 10, 2020. doi:10.1056/NEJMoa2034577<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/33301246/pubmed" id="33301246" target="_blank">33301246</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35653347">
<a name="35653347"></a>Rao AK, Petersen BW, Whitehill F, et al. Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices - United States, 2022. <i>MMWR Morb Mortal Wkly Rep.</i> 2022;71(22):734-742. doi:10.15585/mmwr.mm7122e1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35653347/pubmed" id="35653347" target="_blank">35653347</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35283351">
<a name="35283351"></a>Rawal S, Tackett RL, Stone RH, Young HN. COVID-19 vaccination among pregnant people in the United States: a systematic review. <i>Am J Obstet Gynecol MFM</i>. 2022;4(4):100616. doi:10.1016/j.ajogmf.2022.100616<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35283351/pubmed" id="35283351" target="_blank">35283351</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Manu.1">
<a name="Manu.1"></a>Refer to manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35377399">
<a name="35377399"></a>Ruderman RS, Mormol J, Trawick E, et al. Association of COVID-19 vaccination during early pregnancy with risk of congenital fetal anomalies. <i>JAMA Pediatr</i>. 2022:e220164. doi:10.1001/jamapediatrics.2022.0164<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35377399/pubmed" id="35377399" target="_blank">35377399</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35964614">
<a name="35964614"></a>Sadarangani M, Soe P, Shulha HP, et al; Canadian Immunization Research Network. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study. <i>Lancet Infect Dis</i>. 2022:S1473-3099(22)00426-1. doi:10.1016/S1473-3099(22)00426-1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35964614/pubmed" id="35964614" target="_blank">35964614</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33576785">
<a name="33576785"></a>Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021. <i>JAMA</i>. 2021a;325(11):1101-1102. doi:10.1001/jama.2021.1967<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/33576785/pubmed" id="33576785" target="_blank">33576785</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35129576">
<a name="35129576"></a>Shook LL, Atyeo CG, Yonker LM, et al. Durability of anti-spike antibodies in infants after maternal COVID-19 vaccination or natural infection. <i>JAMA</i>. 2022;327(11):1087-1089. doi:10.1001/jama.2022.1206<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35129576/pubmed" id="35129576" target="_blank">35129576</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Smetzer.2">
<a name="Smetzer.2"></a>Smetzer J, Cohen M, eds. EPINEPHrine administered instead of the COVID-19 vaccine. <i>ISMP Medication Safety Alert! Acute Care Edition</i>. 2022a;27(2):2.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Smetzer.1">
<a name="Smetzer.1"></a>Smetzer J, Cohen M, eds. Additional risk of age-related mix-ups now that our youngest patients are eligible for COVID-19 vaccines. <i>ISMP Medication Safety Alert! Acute Care Edition</i>. 2022b;27(13):3-5.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Spikevax.1">
<a name="Spikevax.1"></a>Spikevax (COVID-19 mRNA vaccine) [prescribing information]. Cambridge, MA: Moderna US Inc; September 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Spikevax.2">
<a name="Spikevax.2"></a>Spikevax (COVID-19 mRNA vaccine) [product monograph]. Toronto, Ontario, Canada: Moderna Biopharma Canada Corp; October 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Spikevax.4">
<a name="Spikevax.4"></a>Spikevax Bivalent Original/Omicron BA.1 (COVID-19 mRNA vaccine) [product monograph]. Toronto, Ontario, Canada: Moderna Biopharma Canada Corp; October 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Spikevax.5">
<a name="Spikevax.5"></a>Spikevax Bivalent Original/Omicron BA.4/5 (COVID-19 mRNA vaccine) [product monograph]. Toronto, Ontario, Canada: Moderna Biopharma Canada Corp; October 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Spikevax.3">
<a name="Spikevax.3"></a>Spikevax XBB.1.5 (COVID-19 mRNA vaccine) [product monograph]. Toronto, Ontario, Canada: Moderna Biopharma Canada Corp; September 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-FDA.14">
<a name="FDA.14"></a>US Food and Drug Administration (FDA). Fact sheet for healthcare providers administering vaccine: Emergency Use Authorization (EUA) of Moderna COVID-19 Vaccine (2023-2024 Formula), for individuals 6 months through 11 years of age. <a href="https://www.fda.gov/media/167208/download" target="_blank">https://www.fda.gov/media/167208/download</a>. Updated September 11, 2023b. Accessed September 13, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-FDA.13">
<a name="FDA.13"></a>US Food and Drug Administration (FDA). Fact sheet for healthcare providers administering vaccine: Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula), for individuals 6 months through 11 years of age. <a href="https://www.fda.gov/media/167211/download" target="_blank">https://www.fda.gov/media/167211/download</a>. Updated September 11, 2023a. Accessed September 13, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-FDA.2">
<a name="FDA.2"></a>US Food and Drug Administration (FDA). Fact sheet for healthcare providers administering vaccine (vaccination providers): Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine to prevent coronavirus disease 2019 (COVID-19): For 5 through 11 years of age; dilute before use. <a href="https://www.fda.gov/media/153714/download" target="_blank">https://www.fda.gov/media/153714/download</a>. Updated October 12, 2022b. Accessed October 13, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-FDA.3">
<a name="FDA.3"></a>US Food and Drug Administration (FDA). Fact sheet for healthcare providers administering vaccine (vaccination providers): Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine to prevent coronavirus disease 2019 (COVID-19): For 12 years of age and older; dilute before use. <a href="https://www.fda.gov/media/153713/download" target="_blank">https://www.fda.gov/media/153713/download</a>. Updated December 22, 2022c. Accessed December 23, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-FDA.4">
<a name="FDA.4"></a>US Food and Drug Administration (FDA). Fact sheet for healthcare providers administering vaccine: Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine to prevent coronavirus disease 2019 (COVID-19): For 12 years of age and older; do not dilute. <a href="https://www.fda.gov/media/153715/download" target="_blank">https://www.fda.gov/media/153715/download</a>. Updated August 31, 2022d. Accessed September 8, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-FDA.9">
<a name="FDA.9"></a>US Food and Drug Administration (FDA). Fact sheet for healthcare providers administering vaccine: Emergency Use Authorization (EUA) of the Moderna COVID-19 Vaccine, bivalent (original and Omicron BA.4/BA.5) to prevent coronavirus disease 2019 (COVID-19): booster dose presentation; For 6 years of age and older; dark blue cap and a label with a gray border. <a href="https://www.fda.gov/media/161318/download" target="_blank">https://www.fda.gov/media/161318/download</a>. Updated December 8, 2022i. Accessed December 19, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-FDA.10">
<a name="FDA.10"></a>US Food and Drug Administration (FDA). Fact sheet for healthcare providers administering vaccine (vaccination providers): Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine, bivalent (original and Omicron BA.4/BA.5) to prevent coronavirus disease 2019 (COVID-19): booster dose presentation; For 12 years of age and older; do not dilute. <a href="https://www.fda.gov/media/161327/download" target="_blank">https://www.fda.gov/media/161327/download</a>. Updated October 12, 2022j. Accessed October 13, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-FDA.15">
<a name="FDA.15"></a>US Food and Drug Administration (FDA). Important information about the correct dosage and administration of Moderna COVID-19 vaccine (2023-2024 formula) for individuals 6 months through 11 years of age. <a href="https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/important-information-about-correct-dosage-and-administration-moderna-covid-19-vaccine-2023-2024" target="_blank">https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/important-information-about-correct-dosage-and-administration-moderna-covid-19-vaccine-2023-2024</a>. Published November 1, 2023c. Accessed November 8, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-FDA.5">
<a name="FDA.5"></a>US Food and Drug Administration (FDA). Letters to health care providers: Possible false RPR reactivity with BioPlex 2200 syphilis total &amp; RPR test kit following a COVID-19 vaccine - letter to clinical laboratory staff and health care providers. <a href="https://www.fda.gov/medical-devices/letters-health-care-providers/possible-false-rpr-reactivity-bioplex-2200-syphilis-total-rpr-test-kit-following-covid-19-vaccine" target="_blank">https://www.fda.gov/medical-devices/letters-health-care-providers/possible-false-rpr-reactivity-bioplex-2200-syphilis-total-rpr-test-kit-following-covid-19-vaccine</a>. Published December 17, 2021. Accessed October 4, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Wallace.1">
<a name="Wallace.1"></a>Wallace M, Woodworth KR, Gargano JW, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12–15 years — United States, May 2021. <i>MMWR</i>. 2021;70:1-4. <a href="https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7020e1-H.pdf" target="_blank">https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7020e1-H.pdf</a>.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33053279">
<a name="33053279"></a>Walsh EE, Frenck RW Jr, Falsey AR, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. <i>N Engl J Med</i>. 2020;383(25):2439-2450. doi:10.1056/NEJMoa2027906<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/33053279/pubmed" id="33053279" target="_blank">33053279</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35666609">
<a name="35666609"></a>Washrawirul C, Triwatcharikorn J, Phannajit J, Ullman M, Susantitaphong P, Rerknimitr P. Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: a systematic review and meta-analysis. <i>J Eur Acad Dermatol Venereol</i>. 2022;36(11):1947-1968. doi:10.1111/jdv.18294<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35666609/pubmed" id="35666609" target="_blank">35666609</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35325550">
<a name="35325550"></a>Whited N, Cervantes J. Antibodies against SARS-CoV-2 in human breast milk after vaccination: a systematic review and meta-analysis. <i>Breastfeed Med</i>. 2022;17(6):475-483. doi:10.1089/bfm.2021.0353<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/35325550/pubmed" id="35325550" target="_blank">35325550</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Woodworth.1">
<a name="Woodworth.1"></a>Woodworth KR, Moulia D, Collins JP, et al. The Advisory Committee on Immunization Practices' interim recommendation for use of Pfizer-BioNTech COVID-19 Vaccine in children aged 5-11 years - United States, November 2021. <i>MMWR Morb Mortal Wkly Rep</i>. 2021;70:1-5.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34757387">
<a name="34757387"></a>Young BE, Seppo AE, Diaz N, et al. Association of human milk antibody induction, persistence, and neutralizing capacity with SARS-CoV-2 infection vs mRNA vaccination. JAMA Pediatr. 2021:e214897. doi:10.1001/jamapediatrics.2021.4897<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/covid-19-mrna-vaccines-pediatric-drug-information/abstract-text/34757387/pubmed" id="34757387" target="_blank">34757387</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 130323 Version 289.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
